CN116082401A - Alpha-carbon chiral phosphine compound and preparation method thereof - Google Patents

Alpha-carbon chiral phosphine compound and preparation method thereof Download PDF

Info

Publication number
CN116082401A
CN116082401A CN202310064532.0A CN202310064532A CN116082401A CN 116082401 A CN116082401 A CN 116082401A CN 202310064532 A CN202310064532 A CN 202310064532A CN 116082401 A CN116082401 A CN 116082401A
Authority
CN
China
Prior art keywords
cdcl
nmr
compound
formula
phosphine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310064532.0A
Other languages
Chinese (zh)
Inventor
徐同玉
李慧君
程龙
李桂琴
孙佩栋
曾凡龙
雷琳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwest University
Shaanxi Coal and Chemical Technology Institute Co Ltd
Original Assignee
Northwest University
Shaanxi Coal and Chemical Technology Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest University, Shaanxi Coal and Chemical Technology Institute Co Ltd filed Critical Northwest University
Priority to CN202310064532.0A priority Critical patent/CN116082401A/en
Publication of CN116082401A publication Critical patent/CN116082401A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6596Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having atoms other than oxygen, sulfur, selenium, tellurium, nitrogen or phosphorus as ring hetero atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2419Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member
    • B01J31/2428Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member with more than one complexing phosphine-P atom
    • B01J31/2433Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member with more than one complexing phosphine-P atom comprising aliphatic or saturated rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32Addition reactions to C=C or C-C triple bonds
    • B01J2231/323Hydrometalation, e.g. bor-, alumin-, silyl-, zirconation or analoguous reactions like carbometalation, hydrocarbation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/10Complexes comprising metals of Group I (IA or IB) as the central metal
    • B01J2531/16Copper
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention belongs to the technical field of asymmetric catalytic synthesis, and particularly relates to an alpha-carbon chiral phosphine compound and a preparation method thereof. In the protective gas atmosphere, carrying out asymmetric boron protonation reaction on a dienylphosphine oxide compound with a structure shown in a formula II, pinacol borate, a copper (I) catalyst, a chiral ligand, an organic alkaline compound and a proton additive in a polar organic solvent to obtain an alpha-carbon chiral phosphine compound with the structure shown in the formula I; the chiral ligand is a cyclic phosphine ligand (S, S) -Ph-BPE or a cyclic phosphine ligand (R, R) -Ph-BPE. The preparation method provided by the invention can synthesize the alpha-carbon chiral phosphine compound with the structure shown in the formula I with high yield and excellent enantioselectivity, the synthesis method is simple and low in cost, and the alpha-carbon chiral phosphine compound can be further converted into a new optical active product.

Description

Alpha-carbon chiral phosphine compound and preparation method thereof
Technical Field
The invention belongs to the technical field of asymmetric catalytic synthesis, and particularly relates to an alpha-carbon chiral phosphine compound and a preparation method thereof.
Background
Chiral phosphine compounds have important applications in the fields of organic synthesis, pharmaceutical chemistry or material science, etc. Chiral phosphine compounds play a significant role in the synthesis of chiral compounds as ligands in organic catalysts or asymmetric catalysis of transition metals. However, the synthesis of chiral phosphine compounds at present mainly depends on a method using a stoichiometric chiral auxiliary reagent or chiral resolution, and the effective chiral reagent has few types, large dosage and limited application range; the chiral resolution method is complicated, the resolution effect is unstable, and the synthesis and the application of chiral phosphine compounds with various structures and multiple functions are greatly limited.
The chiral phosphine compound is synthesized by utilizing an asymmetric catalysis method, and has the advantages of environmental protection, adjustable catalysis system, capability of obtaining various chiral types, diversified structures and the like. Asymmetric boration of phosphine compounds containing unsaturated bonds using transition metal catalysis is an effective method for constructing chiral centers. For example, phosphine compounds containing carbon-carbon double bonds can be prepared into beta-, gamma-or delta-carbon chiral phosphine compounds by asymmetric borohydride under the catalysis of copper or rhodium.
However, the above-described asymmetric boration reaction method is not effective for synthesizing an α -carbon chiral phosphine compound.
Disclosure of Invention
The invention aims to provide an alpha-carbon chiral phosphine compound and a preparation method thereof, wherein the alpha-carbon chiral phosphine compound with a structure shown in a formula I is synthesized through an asymmetric boron protonation reaction with high yield and high enantioselectivity by adopting a copper (I) catalyst as a catalyst, the synthesis method is simple and low in cost, and the alpha-carbon chiral phosphine compound can be further converted into a new optical active product.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides an alpha-carbon chiral phosphine compound, which has a structure shown in a formula I:
Figure BDA0004073659290000011
in the formula I, the R 1 Is C 1~8 Alkyl, C of (2) 3~8 Cycloalkyl, C 1~8 Alkoxy, amino, aryl or substituted aryl groups, said R 1 The substituent on the substituted aryl is fluorine, chlorine, bromine, nitro, trifluoromethyl, C 1~4 Alkyl and C of (C) 1~4 At least one of the alkoxy groups of (a);
the R is 2 Is C 1~4 Alkyl, aryl, substituted aryl or thienyl, R 2 The substituent on the substituted aryl is fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1~4 Alkyl, C of (2) 1~4 Alkoxy, C 1~4 At least one of an alkoxy group, an ester group and a cyano group.
Preferably, said R 1 Is phenyl group,
Figure BDA0004073659290000012
Figure BDA0004073659290000013
MeO-, etO-, or +.>
Figure BDA0004073659290000014
The R is 2 Is phenyl, naphthyl,
Figure BDA0004073659290000015
Figure BDA0004073659290000016
Preferably, the alpha-carbon chiral phosphine compound has any one of the following structures:
Figure BDA0004073659290000021
the invention provides a preparation method of an alpha-carbon chiral phosphine compound, which comprises the following steps:
in a protective gas atmosphere, carrying out asymmetric boron protonation reaction on a dienylphosphine oxide compound with a structure shown in a formula II, pinacol boric acid ester, a copper (I) catalyst, a chiral ligand, an organic alkaline compound and a proton additive in a polar organic solvent to obtain the alpha-carbon chiral phosphine compound; the chiral ligand is a cyclic phosphine ligand (S, S) -Ph-BPE or a cyclic phosphine ligand (R, R) -Ph-BPE;
Figure BDA0004073659290000022
preferably, the copper (I) catalyst is CuCl, cuBr, cuI, cuOAc, cuTc and Cu (CH) 3 CN) 4 PF 6 One or more of the following.
Preferably, the temperature of the asymmetric boron protonation reaction is-30 to-60 ℃.
Preferably, the organic basic compound is sodium t-butoxide.
Preferably, the proton additive is methanol.
Preferably, the mole ratio of the dienylphosphine oxide compound with the structure shown in the formula II and the pinacol borate is 1 (1-2);
the mol ratio of the alkenyl phosphine oxide compound with the structure shown in the formula II to the copper (I) catalyst is 1:0.05;
the mol ratio of the dienylphosphine oxide with the structure shown in the formula II to the chiral ligand is 1:0.06;
the mol ratio of the alkenyl phosphine oxide compound with the structure shown in the formula II to the proton additive is 1:2;
the molar ratio of the alkenyl phosphine oxide compound with the structure shown in the formula II to the organic alkaline compound is 1:0.2.
Preferably, the copper (I) catalyst is CuOAc; the temperature of the asymmetric boron protonation reaction is-55 ℃.
The invention provides an alpha-carbon chiral phosphine compound, which has a structure shown in a formula I, wherein R is 1 Is C 1~8 Alkyl, C of (2) 3~8 Cycloalkyl, C 1~8 Alkoxy, amino, aryl or substituted aryl groups, said R 1 The substituent on the substituted aryl is fluorine, chlorine, bromine, nitro, trifluoromethyl, C 1~4 Alkyl and C of (C) 1~4 At least one of the alkoxy groups of (a); the R is 2 Is C 1~4 Alkyl, aryl, substituted aryl or thienyl, R 2 The substituent on the substituted aryl is fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1~4 Alkyl, C of (2) 1~4 Alkoxy, C 1~4 At least one of an alkoxy group, an ester group and a cyano group. The boron functionalized chiral allylphosphine oxide compound with the structure shown in the formula I can be further converted into a new optical active product, so that the synthesis method of the chiral phosphine compound is expanded, and the application of the chiral phosphine oxide compound in the synthesis of the chiral compound is widened.
The invention provides a preparation method of an alpha-carbon chiral phosphine compound, which comprises the following steps: in the atmosphere of protective gas, the dienylphosphine oxide compound with the structure shown in the formula II and pinacol borate (B) 2 pin 2 ) Carrying out asymmetric boron protonation reaction on copper (I) catalyst, chiral ligand, organic alkaline compound and proton additive in polar organic solvent to obtain the alpha-carbon chiral phosphine compound; the chiral ligand is a cyclic phosphine ligand (S, S) -Ph-BPE or a cyclic phosphine ligand (R, R) -Ph-BPE. The preparation method provided by the invention generates the copper (I) complex in situ by chiral ligand and copper (I) catalyst under the action of organic alkaline compound, and then the copper (I) complex and B 2 pin 2 Generating metal conversion reactionAn active copper boron complex; the alkenyl phosphine oxide compound with the structure shown in the formula II and the copper boron complex undergo a borocupnization reaction to form an allyl copper intermediate; finally, the allyl copper intermediate and the proton additive are protonated to obtain the target product alpha-carbon chiral phosphine compound, and the copper (I) catalyst is regenerated. The preparation method provided by the invention has regioselectivity in the process of inducing the diene boronation due to the electron-withdrawing property of the phosphorus oxygen group, and the obtained allyl copper intermediate is a key step for realizing higher enantioselectivity. The preparation method provided by the invention can synthesize the alpha-carbon chiral phosphine compound with the structure shown in the formula I with high yield and excellent enantioselectivity.
Drawings
FIG. 1 is a diagram of compound 2a in example 1 of the present invention 1 H NMR spectrum;
FIG. 2 shows a single crystal diffraction structure of Compound 6 in the application example of the present invention.
Detailed Description
The invention provides an alpha-carbon chiral phosphine compound, which has a structure shown in a formula I:
Figure BDA0004073659290000031
in the formula I, the R 1 Is C 1~8 Alkyl, C of (2) 3~8 Cycloalkyl, C 1~8 Alkoxy, amino, aryl or substituted aryl groups, said R 1 The substituent on the substituted aryl is fluorine, chlorine, bromine, nitro, trifluoromethyl, C 1~4 Alkyl and C of (C) 1~4 At least one of the alkoxy groups of (a);
the R is 2 Is C 1~4 Alkyl, aryl, substituted aryl or thienyl, R 2 The substituent on the substituted aryl is fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1~4 Alkyl, C of (2) 1~4 Alkoxy, C 1~4 At least one of an alkoxy group, an ester group and a cyano group.
In the present invention, the R 1 Preferably phenyl,
Figure BDA0004073659290000032
Figure BDA0004073659290000033
MeO-, etO-, or +.>
Figure BDA0004073659290000034
In the present invention, the R 2 Preferably phenyl, naphthyl,
Figure BDA0004073659290000035
Figure BDA0004073659290000036
In the present invention, the α -carbon chiral phosphine compound preferably has any one of the following structures:
Figure BDA0004073659290000041
the invention provides a preparation method of an alpha-carbon chiral phosphine compound, which comprises the following steps:
in a protective gas atmosphere, carrying out asymmetric boron protonation reaction on a dienylphosphine oxide compound with a structure shown in a formula II, pinacol boric acid ester, a copper (I) catalyst, a chiral ligand, an organic alkaline compound and a proton additive in a polar organic solvent to obtain the alpha-carbon chiral phosphine compound; the chiral ligand is a cyclic phosphine ligand (S, S) -Ph-BPE or a cyclic phosphine ligand (R, R) -Ph-BPE;
Figure BDA0004073659290000042
in the present invention, all preparation materials/components are commercially available products well known to those skilled in the art unless specified otherwise.
The invention has no special requirement on the source of the alkenyl phosphine oxide compound with the structure shown in the formula II, and the alkenyl phosphine oxide compound is prepared by a preparation method well known to a person skilled in the art.
In the invention, the structural formula of the cyclic phosphine ligand (S, S) -Ph-BPE is shown in a formula III:
Figure BDA0004073659290000043
/>
in the invention, the structural formula of the cyclic phosphine ligand (R, R) -Ph-BPE is shown in a formula IV:
Figure BDA0004073659290000051
in the present invention, the copper (I) catalyst is preferably CuCl, cuBr, cuI, cuOAc, cuTc and Cu (CH) 3 CN) 4 PF 6 More preferably CuOAc.
In the present invention, the organic basic compound is sodium t-butoxide.
In the present invention, the proton additive is methanol.
In the invention, when the proton additive is methanol, the chiral ligand and the copper (I) catalyst generate an alkoxy copper (I) complex in situ under the action of the organic alkaline compound, wherein the alkoxy copper (I) complex is tert-butoxycopper generated by the copper catalyst and alkali tert-butoxide sodium when the catalytic reaction is started, or is reacted with methanol in a catalytic cycle to generate methoxy copper after protonation.
In the present invention, the polar organic solvent is preferably at least one selected from tetrahydrofuran, methyl tert-butyl ether, diethyl ether and toluene, more preferably toluene.
In the present invention, the molar ratio of the alkenylphosphine oxide compound of the structure represented by formula II to the pinacol borate is preferably 1 (1-2), more preferably 1 (1-1.7), and most preferably 1 (1-1.5).
In the present invention, the molar ratio of the alkenylphosphine oxide compound of the structure represented by formula II to the copper (I) catalyst is preferably 1:0.05.
In the present invention, the molar ratio of the dienylphosphine oxide of the structure of formula II to the chiral ligand is preferably 1:0.06.
In the present invention, the molar ratio of the alkenylphosphine oxide compound of the structure represented by formula II to the proton additive is preferably 1:2.
In the present invention, the molar ratio of the alkenylphosphine oxide compound of the structure represented by formula II to the organic basic compound is preferably 1:0.2.
The invention has no special requirement on the dosage of the polar organic solvent, and ensures that the asymmetric boron protonation reaction is smoothly carried out.
In the present invention, the temperature of the asymmetric boron protonation reaction is-30 to-60 ℃, more preferably-55 ℃. In the invention, the heat preservation time of the asymmetric boron protonation reaction is preferably 12-24 h. In the present invention, the asymmetric boron protonation reaction is preferably carried out under stirring.
In the present invention, the shielding gas is preferably nitrogen.
In the present invention, the mixing sequence of the raw materials for the asymmetric boron protonation reaction is preferably as follows: in the atmosphere of protective gas, stirring and mixing the copper (I) catalyst, chiral ligand, organic alkaline compound and polar organic for 30min at room temperature, cooling to the temperature of the asymmetric boron protonation reaction, and sequentially adding pinacol borate, the dienylphosphine oxide compound with the structure shown in the formula II and a proton additive.
In the invention, the reaction liquid is obtained after the asymmetric boron is protonated, and the invention preferably carries out post-treatment on the reaction liquid to obtain the alpha-carbon chiral phosphine compound. In the present invention, the post-treatment preferably includes the steps of: concentrating the reaction liquid to obtain a concentrate; and (3) performing column chromatography purification on the concentrate to obtain the alpha-carbon chiral phosphine compound. In the invention, the eluent used for the column chromatography purification is preferably a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of the petroleum ether to the ethyl acetate is preferably 1:1.
The technical solutions provided by the present invention are described in detail below with reference to the drawings and examples for further illustrating the present invention, but they should not be construed as limiting the scope of the present invention.
In the examples of the present invention, both the reagents and solvents used were commercially available analytical grade. The reaction solvent was distilled under standard conditions to give anhydrous and oxygen-free solvent, and the MTBE, THF and toluene used in the reaction were dried over sodium reflux. The product is purified by using petroleum ether (60-90 ℃) and ethyl acetate as eluent and 200-300 meshes of silica gel. NMR measurements were performed on JEOL 400 and JEOL 600 nuclear magnetic resonance spectrometers with CDCl 3 As solvent in CDCl 3 (delta (1H): 7.26ppm; delta (13C): 77.16 ppm) is the chemical shift reference. Enantioselectivity was analyzed by liquid chromatography.
Wherein, the preparation method of the allenylphosphine oxide compound comprises the following steps:
(1) Preparation of alkynols:
method A:
Figure BDA0004073659290000052
according to the reaction scheme shown in formula 1: to a Schlenk flask, a magneton was added, vacuum was applied and replaced with nitrogen, phenylacetylene (1 equiv) and tetrahydrofuran (0.1M) were sequentially added three times, n-BuLi (2.5M in hexane,1equiv) was added dropwise over 30min at 0℃after the addition was completed, the reaction was stirred at 0℃for one hour, then paraformaldehyde (1.4 equiv) was added, and the reaction was allowed to warm to room temperature and stirred overnight. After the reaction was completed, saturated ammonium chloride was slowly added to quench the reaction, the mixture was allowed to stand for delamination, the organic phase was removed by a separating funnel, the aqueous phase was extracted 3 times with ethyl acetate, the organic phase was combined, the organic phase was washed with a saturated sodium chloride solution, and finally, the organic phase was dried over anhydrous sodium sulfate. Concentration by filtration and isolation of the crude product by column chromatography (petroleum ether: ethyl acetate=2:1, v: v) gave 3-phenyl-2-propyn-1-ol in 86% yield.
Method B:
Figure BDA0004073659290000061
according to the reaction scheme shown in formula 2: adding magneton into Schlenk bottle, vacuumizing, replacing with nitrogen, repeating for three times, adding Pd (PPh) 3 ) 2 Cl 2 (1 mol%) and CuI (2 mol%) followed by sequential addition of Et 3 N (0.25M), aryl iodide (1 equiv) and propynyl alcohol (1.1 equiv), the reaction was heated to 60 ℃ and stirring was continued for 5 hours. After the reaction was completed, cooled to room temperature, the reaction solution was filtered, and the solid residue was taken up in Et 3 N washing, combining the washing and organic phases, removing the solvent by rotary evaporator, and separating the crude product by column chromatography (petroleum ether: ethyl acetate=2:1, v: v) to give the product. Propargyl alcohol as shown in Table 1 was obtained according to method B.
Table 1 propargyl alcohol obtained in method B
Figure BDA0004073659290000062
(2) Preparation of phosphine chloride:
Figure BDA0004073659290000063
according to the reaction scheme shown in formula 3: a250 mL three-necked flask equipped with a reflux condenser and a magnetic stirring bar was evacuated to displace nitrogen three times, magnesium (Mg) chip (1.2 equiv) and a small amount of tetrahydrofuran were sequentially added, followed by adding a small amount of elemental iodine and heating the mixture with a heat gun until the color disappeared. A solution of R-Br (1 equiv) in tetrahydrofuran (1.0M) was added dropwise, with reflux maintained throughout the addition. After the addition was completed, the reaction was heated with an oil bath at 60 ℃ for 4 hours, and then cooled to room temperature.
Figure BDA0004073659290000064
According to the reaction scheme shown in formula 4: nitrogen protectionUnder the condition of adding Et 2 NPCl 2 (1 equiv) and tetrahydrofuran (0.67M), cooled to 0deg.C, and Grignard reagent (RMgBr, 2.05 equiv) was added dropwise, and the reaction was stirred at 0deg.C for 3 hours and then the solvent was removed on a rotary evaporator to leave a brown slurry. Cyclohexane was added to the slurry and filtered through a sand core funnel, and then anhydrous HCl gas was bubbled into the solution with continuous stirring for 1 hour, and the resulting reaction solution was filtered under nitrogen protection and the solvent was removed on a rotary evaporator and immediately used for the next reaction. The phosphine chloride shown in table 2 was prepared as described above.
TABLE 2 preparation of phosphine chloride according to the flow chart shown in formula 4
Figure BDA0004073659290000071
(3) Preparation of the diene:
Figure BDA0004073659290000072
/>
according to the reaction scheme shown in formula 5: adding the magneton into a Schlenk bottle, vacuumizing and replacing with nitrogen, repeating for three times, adding alkynol (1 equiv), triethylamine (1.5 equiv) and tetrahydrofuran (0.33M), cooling to-78deg.C, and cooling to-78deg.C 1 2 The solution of PCl (1.2 equiv) in tetrahydrofuran was slowly added dropwise to the reaction flask, after the dropwise addition was completed, the reaction was warmed to room temperature (3 i and 3j were heated to 60 ℃ for further reaction), after the completion of the reaction, the reaction was quenched by slowly adding dilute HCl (0.1M), allowed to stand for delamination, the organic phase was removed by a separating funnel and the aqueous phase was extracted 3 times with ethyl acetate, the organic phases were combined, washed with saturated sodium chloride solution, and finally dried over anhydrous sodium sulfate. Concentration by filtration and separation of the crude product by column chromatography (petroleum ether: ethyl acetate=1:1, v: v) gives the dienylphosphino-oxy compounds shown in table 3.
TABLE 3 Bisphinoxy Compounds used in the examples of the invention
Figure BDA0004073659290000073
Example 1
Figure BDA0004073659290000081
According to the reaction scheme shown in formula 6: taking 25mL Schlenk tube, adding cuprous acetate (accounting for 5mol% of the dienylphosphine oxide) and (S, S) -Ph-BPE (accounting for 6mol% of the dienylphosphine oxide) under the protection of nitrogen, stirring for 30min at room temperature, cooling to-55deg.C, adding sodium tert-butoxide (accounting for 20mol% of the dienylphosphine oxide) and toluene (2 mL), adding B 2 pin 2 (1.2 equiv), followed by addition of a dienylphosphino-oxy compound (0.2 mmol,1.0 equiv) and methanol (2 equiv). After the reaction is finished, the reaction solution is quenched by an ammonium chloride solution and is directly concentrated, and the crude product is separated by column chromatography (petroleum ether: ethyl acetate=1:1, v: v) to obtain a target product, namely the alpha-carbon chiral phosphine compound with the structure shown in the formula I; wherein the dienylphosphino compound is a dienylphosphino compound of the above-described method, which is designated 1a,1b,1c,1d,1e,1f,1g,1h,1i,1j,1k,1l,1m,1n,1o,1p,1q,1r,3a,3b,3c,3d,3e,3f,3g,3h,3i,3j or 3k of Table 3;
the α -carbon chiral phosphine compounds prepared in this example are specifically α -carbon chiral phosphine compounds having the structure shown in formula I and designated as 2a,2b,2c,2d,2e,2f,2g,2h,2I,2j,2k,2l,2m,2n,2o,2p,2q,2r,4a,4b,4c,4d,4e,4f,4g,4h,4I,4j or 4k in tables 4 and 5;
TABLE 4 specific Structure, yield and ee values of partial alpha-carbon chiral phosphine Compounds a
Figure BDA0004073659290000082
TABLE 5 specific Structure, yield and ee values of the remaining alpha-carbon chiral phosphine compounds a
Figure BDA0004073659290000091
From tables 4 and 5, it can be derived that:
when the para-position is halogen substituent (F, cl and Br), the reactants are smoothly subjected to asymmetric boron protonation, giving 2b-d in excellent yields and high ee values. The reactants with electron donating groups also gave the corresponding products 2e-g in excellent yields and ee values of greater than 96%, while the electron withdrawing groups reduced the enantioselectivity (2 h-j). When the α -benzene ring bears a meta substituent, the dienyl diphenylphosphine oxide reactant was successfully converted to the corresponding products 2k and 2l in 99%, 81% yield and 95%, 93% ee, respectively. When the alpha-phenyl group contains ortho-substitution, the effect of steric hindrance is observed, giving the products 2m and 2n in moderate yields, with ee values of 76% and 89%, respectively, whereas the naphthyl-substituted substrate gives the product 2o in 60% yield and 44% ee value. Thienyl substituted dienyldiphenylphosphinoxide was obtained in 95%, 85% yield and 94%, 81% ee value for the corresponding products 2p and 2q, respectively. Boron protonation of the α -methyl-dienyl diphenylphosphino oxide gives the corresponding product 2r in 68% yield and 79% ee. When the phosphorus atom contains an aromatic substituent which is para, meta or ortho, the asymmetric boron protonation proceeds smoothly to give the products 4a-f in 50-83% yield and 78-96% enantioselectivity. Under these conditions, the dicyclohexyl-or diisobutyl-substituted dienylphosphinoxide compound gave the desired product (4 g-h) in moderate yield and good enantiomeric excess (80-86% ee). The dienylphosphonate is also suitable for this reaction, with yields of 45% and 88% for 4i and 4j, respectively, and ee values of 94% and 95%, respectively. Product 4k was obtained from the dienylphosphindiamide in moderate yields and ee values.
Example 2
100mL Schlenk tube was taken and charged with copper acetate (19.6 mg,5 mol%) respectively, (S, S) -Ph-BPE (97.3 mg,6 mol%), sodium tert-butoxide (20 mol%) and toluene (30 mL) under nitrogen, stirred at room temperature for 30min, cooled to-55deg.C, and charged with B 2 pin 2 (0.98 g,3.84 mmol) followed by 1a (1.0 g,3.2 mmol) and methanol (2 equiv). To be reacted to completionAfter that, the reaction solution was directly concentrated, and the crude product was separated by column chromatography (petroleum ether: ethyl acetate=1:1, v:v) to give the objective product 2a.
This implementation examined gram-scale reaction of asymmetric boron protonation of 1a, and 2a was obtained in 96% yield and 96% ee value, demonstrating the effectiveness of the preparation method provided by the present invention.
Example 3
The present example screens for the types of chiral ligands:
according to the reaction scheme shown in formula 7, the present example uses substrates 1a and B 2 pin 2 The reaction of (2) is to optimize the kind of chiral ligand for the model. At room temperature, cu (CH) 3 CN) 4 PF 6 The ligand used in the reaction was screened using tetrahydrofuran as the solvent, sodium tert-butoxide as the base and methanol as the proton additive, and the experimental parameters are shown in table 6.
Figure BDA0004073659290000101
TABLE 6 kinds of chiral ligands and specific reaction conditions used in example 3
Figure BDA0004073659290000102
Appendix 1:1a (0.2 mmol), B 2 pin 2 (0.24mmol),Cu(CH 3 CN) 4 PF 6 (5 mol% of 1 a), L1-8 (6 mol% of 1 a), L9-10 (12 mol% of 1 a), naO t Bu (20 mol% of 1 a), meOH (0.4 mmol), THF (2 mL).
Appendix 2: and (5) separating and purifying to obtain the yield.
L1 to L10 in Table 6 are respectively:
Figure BDA0004073659290000103
the results in Table 6 show that when (S) -BINAP is used as ligand, the yield and enantioselectivity of the reaction are relatively low, 20% and 13% ee (Table 6, SEQ ID NO: 1), respectively, and then the present example tries again to try ligand L2 of BINAP skeleton, while the yield is increased, the ee value is still low (Table 6, SEQ ID NO: 2). When highly sterically hindered L3 was used as ligand, the yield was 49% (Table 6, SEQ ID NO: 3). When ligand L4 was used, the product was obtained in 72% yield and 13% ee (Table 6, SEQ ID NO: 4). The cyclic phosphine ligand (S, S) -Ph-BPE (L5) promotes the reaction, the yield and the enantioselectivity are obviously improved, and the ee value of the product is 63% (Table 6, sequence number 5). When L5 was replaced with ligand L6 of the same backbone, the reaction was almost enantioselective (Table 6, SEQ ID NO: 6). No reaction occurred when L7 was used as ligand (table 6, no. 7), and the ee value of the product was 35% when L8 was used as ligand (table 6, no. 8). Further screening showed that the product was obtained in similar yields but without enantioselectivity when using other ligands such as (R) -MeO-MOP and phosphoramidite ligands (Table 6, SEQ ID NO: 9, 10). As is clear from the results in Table 6, ligand L5 was the best ligand.
Example 4
The present example screens the copper (I) catalyst species:
example 3 the optimum chiral ligand was determined and the effect of the copper (I) catalyst on the reaction was investigated in accordance with the reaction scheme shown in equation 8 and the reaction conditions in table 7 by lowering the reaction temperature to-30 c in order to further increase the enantioselectivity of the reaction, and the results are shown in table 7.
As is clear from the results in Table 7, when the reaction temperature was lowered from room temperature to-30 ℃, the yield and the enantioselectivity were significantly improved. This example first investigated the effect of cuprous salts on the reaction catalysis. When Cu (CH) 3 CN) 4 PF 6 As a catalyst, the yield and ee value were increased to 77% and 85%, respectively (Table 7, SEQ ID NO: 1). When CuCl was used as catalyst, the product was obtained with a similar ee (table 7, serial No. 2). When CuBr or CuI was used as the catalyst, the yields could be about 80%, but the ee values were relatively low, only 48% and 37%, respectively (Table 7, SEQ ID NO: 3, 4). CuOAc as catalyst gave the product in 88% yield and 90% ee (table 7, no. 5). While when CuTc is used as a catalyst, the yield is 80 percent, and the ee value is87% (Table 9, number 6). When using CuCl 2 As a catalyst, the productivity was significantly lowered, but the ee value was maintained at 80% or more (Table 7, SEQ ID NO: 7). When using CuBr 2 As a catalyst, the ee value was only 33% (Table 7, SEQ ID NO: 8). Cu (OAc) 2 、Cu(CF 3 SO 3 ) 2 Similar yields and poor enantioselectivities were obtained as catalysts (Table 7, ser. No. 9, 10). Thus CuOAc is the best catalyst.
Figure BDA0004073659290000111
TABLE 7 screening of copper (I) catalysts 1
Figure BDA0004073659290000112
Appendix 1:1a (0.2 mmol), B 2 pin 2 (0.24mmol),Cu catalyst(5mol%),(S,S)-Ph-BPE(6mol%),NaO t Bu(20mol%),MeOH(0.4mmol),THF(2mL)。
Appendix 2: and (5) separating and purifying to obtain the yield.
Example 5
The reaction conditions were screened in this example;
the reaction was carried out according to the reaction scheme described in formula 9 and the reaction conditions of Table 10, and the results are shown in Table 8.
As can be seen from the results in Table 10, the enantioselectivity of the product did not show a significant change when the temperature was lowered to-40 ℃ (Table 8, SEQ ID Nos. 1, 2). When KO is used t Bu instead of NaO t No reaction occurred when Bu was reacted (table 8, no. 3); when using LiO t Bu as the base of the reaction gave an ee value of only 43% (Table 8, SEQ ID NO: 4). With NaO t Bu was used as the base for the reaction, and the yield and ee value of the product were significantly reduced as the temperature was further reduced to-50 ℃ (Table 8, SEQ ID NO: 5). Insoluble solids were observed in the examples during the reaction, which is presumably due to the low solubility of the reactants and products. To further increase the enantioselectivity, a different approach was followedToluene, diethyl ether and methyl tertiary butyl ether. The yield of the product was 93% with toluene as solvent, the ee value was 93% (Table 8, SEQ ID NO: 6), whereas the yields were only 60% and 40% with diethyl ether and methyl tert-butyl ether, respectively (Table 8, SEQ ID NO: 7, 8). The desired product was obtained in 99% yield and 98% ee at-55℃with toluene as a solvent by further lowering the temperature (Table 8, SEQ ID NO: 9). When the temperature was lowered to-60 ℃, the yield was 92% (Table 8, SEQ ID NO: 10). Thus, the present invention determines the optimal conditions for the reaction: 5mol% CuOAc as catalyst, 6mol% (S, S) -Ph-BPE as ligand, 20mol% sodium tert-butoxide as base, toluene as solvent, the reaction is carried out at-55 ℃.
Figure BDA0004073659290000113
TABLE 8 optimization of reaction conditions 1
Figure BDA0004073659290000114
Figure BDA0004073659290000121
Appendix 1:1a (0.2 mmol), B 2 pin 2 (0.24mmol),CuOAc(5mol%),(S,S)-Ph-BPE(6mol%),base(20mol%),MeOH(0.4mmol),solvent(2mL)。
Appendix 2: and (5) separating and purifying to obtain the yield.
The structural characterization data of the dienylphosphine oxide compound with the structure shown in the formula II and the alpha-carbon chiral phosphine compound with the structure shown in the formula I, which are prepared in the embodiment of the invention, are specifically as follows:
Figure BDA0004073659290000122
diphenyl(1-(4-(trifluoromethoxy)phenyl)propa-1,2-dien-1-yl)phosphine oxide(1g):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,1.17g,74%yield,white solid,m.p.90-91℃. 1 H NMR(400MHz,CDCl 3 )δ7.77-7.72(m,4H),7.64(d,J=8.8Hz,2H),7.54-7.50(m,2H),7.48-7.42(m,4H),7.10(d,J=8.4Hz,2H),4.92(d,J=10.8Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.5(d,J=6.6Hz),148.6,132.2(d,J=2.3Hz),131.85(d,J=9.7Hz),131.8(d,J=105.7Hz),130.7(d,J=5.9Hz),129.8(d,J=4.5Hz),128.5(d,J=12.6Hz),121.1,120.8,99.8(d,J=10.0Hz),79.0(d,J=12.2Hz). 31 P NMR(162MHz,CDCl 3 )δ29.3. 19 F NMR(376MHz,CDCl 3 )δ-57.8.HRMS(ESI-MS)m/z calcd.for C 22 H 17 F 3 O 2 P[M+H] + :401.0913,found:401.0918.
Figure BDA0004073659290000123
methyl 4-(1-(diphenylphosphoryl)propa-1,2-dien-1-yl)benzoate(1h):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.86g,84%yield,white solid,m.p.156-157℃. 1 H NMR(400MHz,CDCl 3 )δ7.91(d,J=8.4Hz,2H),7.77-7.68(m,6H),7.51(dt,J=7.6,1.2Hz,2H),7.45-7.41(m,4H),4.95(d,J=10.4Hz,2H),3.86(s,3H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ214.0(d,J=6.3Hz),166.8,136.9(d,J=5.4Hz),132.1(d,J=2.2Hz),131.8(d,J=9.6Hz),131.76(d,J=100Hz),129.9,129.1,128.5(d,J=12.6Hz),128.2(d,J=4.6Hz),100.6(d,J=100.5Hz),79.2(d,J=12.2Hz),52.2. 31 P NMR(162MHz,CDCl 3 )δ29.2.HRMS(ESI-MS)m/z calcd.for C 23 H 19 O 3 PK[M+K] + :413.0703,found:413.0702.
Figure BDA0004073659290000124
diphenyl(1-(4-(trifluoromethyl)phenyl)propa-1,2-dien-1-yl)phosphine oxide(1i):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.77g,39%yield,white solid,m.p.89-90℃. 1 H NMR(400MHz,CDCl 3 )δ7.77-7.72(m,6H),7.55-7.39(m,8H),4.96(d,J=10.8Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.9(d,J=6.2Hz),135.9(d,J=2.9Hz),132.3,132.1,131.8(d,J=9.6Hz),131.6(d,J=99.9Hz),129.6(q,J=32.7Hz),128.55,128.54(d,J=12.2Hz),125.6(d,J=3.6Hz),124.1(q,J=273.2Hz),100.2(d,J=99.8Hz),79.3(d,J=11.9Hz). 31 P NMR(162MHz,CDCl 3 )δ29.1. 19 F NMR(376MHz,CDCl 3 )δ-62.7.HRMS(ESI-MS)m/z calcd.for C 22 H 17 F 3 OP[M+H] + :385.0964,found:385.0964.
Figure BDA0004073659290000131
4-(1-(diphenylphosphoryl)propa-1,2-dien-1-yl)benzonitrile(1j):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,1.47g,91%yield,white solid,m.p.150-151℃. 1 H NMR(400MHz,CDCl 3 )δ7.76-7.71(m,6H),7.56-7.54(m,4H),7.45(dt,J=7.6,2.8Hz,4H),4.99(d,J=10.8Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ214.0(d,J=6.3Hz),137.3(d,J=5.6Hz),132.40,132.36(d,J=2.6Hz),131.8(d,J=9.6Hz),131.5(d,J=108.3Hz),128.8(d,J=4.5Hz),128.6(d,J=12.6Hz),118.8,111.2,100.3(d,J=100.2Hz),79.5(d,J=11.8Hz). 31 P NMR(162MHz,CDCl 3 )δ29.0.HRMS(ESI-MS)m/z calcd.for C 22 H 17 NOP[M+H] + :342.1042,found:342.1032.
Figure BDA0004073659290000132
(1-(3-chloro-4-fluorophenyl)propa-1,2-dien-1-yl)diphenylphosphine oxide(1k):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,1.47g,86%yield,white solid,m.p.133-134℃. 1 H NMR(400MHz,CDCl 3 )δ7.76-7.71(m,4H),7.63(dd,J=6.8,2.0Hz,1H),7.58-7.50(m,3H),7.47-7.42(m,4H),7.01(t,J=8.8Hz,1H),4.93(d,J=10.8Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.3(d,J=6.9Hz),157.5(d,J=251.3Hz),132.2(d,J=2.1Hz),131.8(d,J=9.7Hz),131.5(d,J=107.8Hz),130.3(d,J=5.2Hz),129.3,129.24,129.2,128.5(d,J=12.6Hz),128.1(dd,J=6.8,4.7Hz),121.2(d,J=18.2Hz),116.7(d,J=21.4Hz),99.2(d,J=100.7Hz),79.3(d,J=12.2Hz). 31 P NMR(162MHz,CDCl 3 )δ29.1. 19 F NMR(376MHz,CDCl 3 )δ-116.4.HRMS(ESI-MS)m/z calcd.for C 21 H 16 ClFOP[M+H] + :369.0606,found:369.0616.
Figure BDA0004073659290000133
(1-(3-methoxyphenyl)propa-1,2-dien-1-yl)diphenylphosphine oxide(1l):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,1.41g,69%yield,viscous oil. 1 H NMR(400MHz,CDCl 3 )δ7.79-7.78(m,1H),7.77-7.75(m,2H),7.74-7.73(m,1H),7.52-7.47(m,2H),7.45-7.40(m,4H),7.21-7.13(m,3H),6.76-6.73(m,1H),4.89(d,J=10.8Hz,2H),3.70(s,3H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.6(d,J=6.9Hz),159.7,133.3(d,J=5.5Hz),132.2(d,J=107.7Hz),132.0(d,J=2.9Hz),131.9(d,J=9.6Hz),129.7,128.4(d,J=12.6Hz),120.9(d,J=5.0Hz),113.8,113.5(d,J=5.1Hz),100.8(d,J=101.0Hz),78.6(d,J=12.5Hz),55.3. 31 P NMR(162MHz,CDCl 3 )δ28.9.HRMS(ESI-MS)m/z calcd.for C 22 H 20 O 2 P[M+H] + :347.1195,found:347.1183.
Figure BDA0004073659290000134
(1-(2-chlorophenyl)propa-1,2-dien-1-yl)diphenylphosphine oxide(1m):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.64g,37%yield,white solid,m.p.107-108℃. 1 H NMR(400MHz,CDCl 3 )δ7.83-7.78(m,4H),7.77-7.75(m,1H),7.51-7.47(m,2H),7.44-7.40(m,4H),7.34-7.32(m,1H),7.18-7.12(m,2H),4.86(d,J=10.8Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.7(d,J=6.3Hz),133.9(d,J=5.9Hz),132.0(d,J=2.4Hz),131.8(d,J=9.6Hz),131.6(d,J=107.2Hz),131.1(d,J=1.9Hz),130.7(d,J=5.9Hz),130.1,129.2,128.3(d,J=12.5Hz),127.0,97.5(d,J=101.7Hz),77.9(d,J=12.1Hz). 31 P NMR(162MHz,CDCl 3 )δ28.8.HRMS(ESI-MS)m/z calcd.for C 21 H 17 ClOP[M+H] + :351.0700,found:351.0704.
Figure BDA0004073659290000141
(1-(2-iodophenyl)propa-1,2-dien-1-yl)diphenylphosphine oxide(1n):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,1.21g,87%yield,white solid,m.p.106-107℃. 1 H NMR(400MHz,CDCl 3 )δ7.86-7.79(m,5H),7.69(dt,J=8.0,1.2Hz,1H),7.52-7.47(m,2H),7.45-7.40(m,4H),7.24-7.22(m,1H),6.89(dt,J=7.6,1.2Hz,1H),4.96(d,J=10.4Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.1(d,J=6.7Hz),140.0,135.7(d,J=5.9Hz),132.02(d,J=9.2Hz),132.01,131.4(d,J=99.5Hz),130.2,129.5,128.4,128.3(d,J=12.5Hz),103.7(d,J=100.9Hz),100.7(d,J=5.6Hz),79.3(d,J=12.0Hz). 31 P NMR(162MHz,CDCl 3 )δ27.9.HRMS(ESI-MS)m/z calcd.for C 21 H 17 IOP[M+H] + :443.0056,found:443.0061.
Figure BDA0004073659290000142
(1-(naphthalen-1-yl)propa-1,2-dien-1-yl)diphenylphosphine oxide(1o):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.63 g,54%yield,white solid,m.p.141-142℃. 1 H NMR(400MHz,CDCl 3 )δ8.14(d,J=8.0Hz,1H),7.82-7.77(m,5H),7.72(d,J=8.0Hz,1H),7.67(d,J=7.2Hz,1H),7.51-7.43(m,4H),7.40-7.33(m,5H),4.91(d,J=10.8Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.6(d,J=6.7Hz),134.1,132.0,131.9(d,J=9.5Hz),131.8(d,J=4.6Hz),131.78(d,J=106.6Hz),129.2(d,J=4.9Hz),128.6(d,J=9.1Hz),128.3(d,J=12.5Hz),127.6(d,J=3.7Hz),126.3,125.9,125.4,125.1,98.3(d,J=98.7Hz),76.9(d,J=15.7Hz). 31 P NMR(162MHz,CDCl 3 )δ28.0.HRMS(ESI-MS)m/z calcd.for C 25 H 20 OP[M+H] + :367.1246,found:367.1250.
Figure BDA0004073659290000143
diphenyl(1-(thiophen-3-yl)propa-1,2-dien-1-yl)phosphine oxide(1p):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.57g,66%yield,reddish solid,m.p.133-134℃. 1 H NMR(400MHz,CDCl 3 )δ7.78-7.73(m,4H),7.54-7.50(m,3H),7.46-7.42(m,4H),7.23-7.21(m,1H),7.16(d,J=5.2Hz,1H),4.89(d,J=11.2Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.0(d,J=6.6Hz),132.1(d,J=2.4Hz),131.9(d,J=9.6Hz),131.8(d,J=107.6Hz),131.2(d,J=5.7Hz),128.4(d,J=12.5Hz),127.3(d,J=5.9Hz),125.5,123.8(d,J=2.9Hz),96.6(d,J=102.2Hz),78.7(d,J=12.5Hz). 31 P NMR(162MHz,CDCl 3 )δ29.3.HRMS(ESI-MS)m/z calcd.for C 19 H 16 OPS[M+H] + :323.0654,found:323.0650.
Figure BDA0004073659290000144
diphenyl(1-(thiophen-2-yl)propa-1,2-dien-1-yl)phosphine oxide(1q):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,1.32g,83%yield,yellow solid,m.p.111-112℃. 1 H NMR(400MHz,CDCl 3 )δ7.80-7.79(m,1H),7.78-7.76(m,2H),7.75-7.74(m,1H),7.55-7.50(m,2H),7.47-7.42(m,4H),7.28-7.27(m,1H),7.18(d,J=5.2Hz,1H),6.89-6.87(m,1H),4.95(d,J=10.8Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ212.3(d,J=5.9Hz),134.1(d,J=8.7Hz),132.2(d,J=2.4Hz),131.9(d,J=9.7Hz),131.6(d,J=108.2Hz),128.4(d,J=12.7Hz),127.9,127.6(d,J=2.6Hz),125.7,96.5(d,J=100.7Hz),79.5(d,J=11.9Hz). 31 PNMR(162MHz,CDCl 3 )δ28.7.HRMS(ESI-MS)m/z calcd.for C 19 H 16 OPS[M+H] + :323.0654,found:323.0662.
Figure BDA0004073659290000151
/>
bis(4-fluorophenyl)(1-phenylpropa-1,2-dien-1-yl)phosphine oxide(3a):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.53g,31%yield,yellow solid,m.p.98-99℃. 1 H NMR(400MHz,CDCl 3 )δ7.86-7.74(m,2H),7.57(d,J=6.8Hz,4H),7.30-7.11(m,7H),4.92(d,J=10.8Hz,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.6(d,J=7.0Hz),165.2(dd,J=254.4,3.0Hz),134.4,134.3,134.2,131.7(dd,J=29.2,5.5Hz),128.9,128.7(d,J=65.1Hz),128.3(d,J=4.9Hz),128.0(dd,J=111.4,3.0Hz),115.9(dd,J=21.6,13.9Hz),100.9(d,J=102.7Hz),78.9(d,J=12.6Hz). 31 P NMR(162MHz,CDCl 3 )δ27.7. 19 F NMR(376MHz,CDCl 3 )δ-106.3.HRMS(ESI-MS)m/z calcd.for C 21 H 16 F 2 OP[M+H] + :353.0901,found:353.0892.
Figure BDA0004073659290000152
bis(3,5-dimethylphenyl)(1-phenylpropa-1,2-dien-1-yl)phosphine oxide(3b):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.86g,46%yield,white solid,m.p.125-126℃. 1 H NMR(400MHz,CDCl 3 )δ7.57(d,J=8.0Hz,2H),7.35(d,J=12.4Hz,4H),7.26-7.22(m,2H),7.16(t,J=7.2Hz,1H),7.10(s,2H),4.89(d,J=10.8Hz,2H),2.30(s,12H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.6(d,J=6.8Hz),137.9(d,J=13.2Hz),133.7(d,J=2.6Hz),132.2(d,J=5.2Hz),131.9(d,J=106.5Hz),129.4(d,J=9.7Hz),128.6,128.4(d,J=4.6Hz),127.5,100.8(d,J=99.8Hz),78.3(d,J=12.3Hz),21.4. 31 P NMR(162MHz,CDCl 3 )δ30.4.HRMS(ESI-MS)m/z calcd.for C 25 H 25 OPNa[M+Na] + :395.1535,found:395.1530.
Figure BDA0004073659290000153
(1-(4-bromophenyl)propa-1,2-dien-1-yl)bis(3,5-dimethylphenyl)phosphine oxide(3c):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,1.28g,61%yield,white solid,m.p.67-68℃. 1 H NMR(400MHz,CDCl 3 )δ7.47(d,J=8.4Hz,2H),7.36-7.31(m,4H),7.11(s,2H),4.89(d,J=10.8Hz,2H),2.30(s,12H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.4(d,J=6.7Hz),138.1(d,J=13.2Hz),133.8(d,J=2.5Hz),131.7,131.6(d,J=106.6Hz),131.4(d,J=5.2Hz),130.0(d,J=4.6Hz),129.4(d,J=9.6Hz),121.7,100.2(d,J=99.5Hz),78.8(d,J=12.0Hz),21.4. 31 P NMR(162MHz,CDCl 3 )δ30.4.HRMS(ESI-MS)m/z calcd.for C 25 H 24 BrOPNa[M+Na] + :475.0623,found:475.0618.
Figure BDA0004073659290000154
bis(3-methoxyphenyl)(1-(p-tolyl)propa-1,2-dien-1-yl)phosphine oxide(3d):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.54g,46%yield,yellow viscous oil. 1 H NMR(400MHz,CDCl 3 )δ7.47(d,J=8.0Hz,2H),7.37(d,J=1.6Hz,1H),7.34-7.29(m,3H),7.26-7.22(m,2H),7.07-7.00(m,4H),4.88(d,J=10.8Hz,2H),3.79(s,6H),2.67(s,3H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.4(d,J=6.7Hz),159.5(d,J=15.4Hz),137.6,133.5(d,J=107.0Hz),129.51(d,J=14.9Hz),129.49,129.1,128.9(d,J=5.4Hz),128.2(d,J=4.7Hz),124.2(d,J=9.8Hz),118.3(d,J=1.4Hz),116.5(d,J=10.5Hz),100.5(d,J=101.3Hz),78.5(d,J=12.8Hz),55.5,21.3. 31 P NMR(162MHz,CDCl 3 )δ30.2.HRMS(ESI-MS)m/z calcd.for C 24 H 23 O 3 PNa[M+Na] + :413.1277,found:413.1274.
Figure BDA0004073659290000161
bis(2-methoxyphenyl)(1-phenylpropa-1,2-dien-1-yl)phosphine oxide(3e):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.42 g,22%yield,white solid,m.p.118-119℃. 1 H NMR(400MHz,CDCl 3 )δ7.70(dd,J=7.6,1.2Hz,1H),7.66(dd,J=7.6,1.2Hz,1H),7.62(d,J=7.6Hz,2H),7.44(t,J=7.6Hz,2H),7.22(t,J=7.2Hz,2H),7.15(t,J=7.2Hz,1H),6.99-6.95(m,2H),6.84(dd,J=8.0,5.2Hz),4.87(d,J=11.2Hz,2H),3.63(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ213.3(d,J=6.7Hz),161.4(d,J=2.1Hz),134.5(d,J=8.4Hz),133.7,133.0(d,J=5.7Hz),128.4,128.2(d,J=4.8Hz),127.2,120.45(d,J=110.5Hz),120.40(d,J=12.6Hz),110.9(d,J=6.9Hz),100.2(d,J=107.9Hz),77.2(d,J=14.3Hz),55.6. 31 P NMR(162MHz,CDCl 3 )δ27.9.HRMS(ESI-MS)m/z calcd.for C 23 H 21 O 3 PNa[M+Na] + :399.1121,found:399.1121.
Figure BDA0004073659290000162
/>
(1-phenylpropa-1,2-dien-1-yl)di-o-tolylphosphine oxide(3f):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.34g,18%yield,white solid,m.p.107-108℃. 1 H NMR(400MHz,CDCl 3 )δ7.73(d,J=8.0Hz,2H),7.43-7.38(m,4H),7.31-7.20(m,5H),7.16-7.13(m,2H),4.82(d,J=10.8Hz,2H),2.58(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ212.7(d,J=6.9Hz),143.3(d,J=7.8Hz),132.9(d,J=12.5Hz),132.3(d,J=4.8Hz),132.0(d,J=2.3Hz),131.8(d,J=11.0Hz),130.5(d,J=105.3Hz),128.8,128.5(d,J=4.4Hz),127.7,125.4(d,J=13.3Hz),100.3(d,J=99.1Hz),77.8(d,J=12.5Hz),21.8(d,J=3.8Hz). 31 P NMR(162MHz,CDCl 3 )δ36.4.HRMS(ESI-MS)m/z calcd.for C 23 H 21 OPNa[M+Na] + :367.1222,found:367.1226.
Figure BDA0004073659290000163
diisobutyl(1-phenylpropa-1,2-dien-1-yl)phosphine oxide(3h):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,0.61g,74%yield,white oil. 1 H NMR(400MHz,CDCl 3 )δ7.61(d,J=8.0Hz,2H),7.34-7.30(m,2H),7.26-7.23(m,1H),5.16(d,J=10.0Hz,2H),2.19-2.06(m,2H),1.91-1.83(m,2H),1.78-1.70(m,2H),1.03-1.00(m,12H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ211.3(d,J=6.6Hz),132.6(d,J=4.9Hz),128.7,128.4(d,J=3.8Hz),127.7,100.9(d,J=86.7Hz),77.9(d,J=11.1Hz),38.7(d,J=69.1Hz),24.7(d,J=8.6Hz),23.8(d,J=3.7Hz). 31 P NMR(162MHz,CDCl 3 )δ40.9.HRMS(ESI-MS)m/z calcd.for C 17 H 25 OPNa[M+Na] + :277.1716,found:277.1715.
Figure BDA0004073659290000164
dimethyl(1-phenylpropa-1,2-dien-1-yl)phosphonate(3i):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=2:1)as eluent,0.70g,62%yield,green solid,m.p.117-118℃. 1 H NMR(400MHz,CDCl 3 )δ7.52(d,J=8.0Hz,1H),7.34-7.30(m,2H),7.26-7.21(m,1H),5.32(d,J=3.2Hz,2H),3.76(d,J=11.2Hz). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ214.0(d,J=4.5Hz),128.9(d,J=22.6Hz),128.7,127.9,127.6(d,J=6.1Hz),96.1(d,J=190.6Hz),78.5(d,J=14.7Hz),53.3(d,J=6.1Hz). 31 P NMR(162MHz,CDCl 3 )δ18.3.HRMS(ESI-MS)m/z calcd.for C 11 H 14 O 3 P[M+H] + :225.0675,found:225.0673.
Figure BDA0004073659290000171
(3k):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=2:1)as eluent,0.81g,53%yield,brown solid,m.p.47-48℃. 1 H NMR(400MHz,CDCl 3 )δ7.70(d,J=8.0Hz,2H),7.32-7.29(m,2H),7.21(d,J=7.2Hz,1H),5.11(d,J=11.2Hz,2H),3.12-3.04(m,8H),1.04(t,J=7.2Hz,12H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ212.6(d,J=4.4Hz),133.1(d,J=6.1Hz),128.3,128.1(d,J=4.9Hz),127.2,100.2(d,J=150.8Hz),76.7(d,J=12.9Hz),39.5(d,J=4.4Hz),14.2(d,J=1.3Hz). 31 P NMR(162MHz,CDCl 3 )δ28.0.HRMS(ESI-MS)m/z calcd.for C 17 H 28 N 2 OP[M+H] + :307.1934,found:307.1930.
Figure BDA0004073659290000172
diphenyl(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)phosphine oxide(2a):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,87.8mg,99%yield,98%ee,white solid,m.p.159-160℃. 1 H NMR(400MHz,CDCl 3 )δ7.91-7.87(m,2H),7.52-7.41(m,7H),7.32(t,J=7.2Hz,1H),7.26-7.22(m,2H),7.18-7.10(m,3H),6.68(br,1H),6.11(t,J=2.4Hz,1H),4.63(d,J=7.6Hz,1H),1.15(s,6H),1.10(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ137.0(d,J=5.2Hz),135.9(d,J=9.2Hz),133.9(d,J=4.8Hz),132.9(d,J=4.6Hz),131.381(d,J=1.7Hz),131.379(dd,J=44.3,8.7Hz),130.2(d,J=6.7Hz),128.251,128.250(dd,J=34.7,11.5Hz),126.7,84.0,47.6(d,J=66.2Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ31.0.[α] D 20 =-83.3(c=1.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 27 H 31 BO 3 P[M+H] + :445.2103,found:445.2118.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=13.4min(minor),20.0min(major).
Figure BDA0004073659290000173
(1-(4-fluorophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)diphenylphosphine oxide(2b):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,83.2mg,90%yield,97%ee,white solid,m.p.196-197℃. 1 H NMR(400MHz,CDCl 3 )δ7.90-7.85(m,2H),7.51-7.44(m,5H),7.37-7.32(m,3H),7.27-7.24(m,2H),6.85(t,J=8.8Hz,2H),6.64(br,1H),6.09-6.08(m,1H),4.61(d,J=6.8Hz,1H),1.15(s,6H),1.09(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ161.9(d,J=246.2Hz),135.8(d,J=8.7Hz),133.7(d,J=17.8Hz),132.8,132.6(d,J=3.8Hz),131.8,131.7,131.6,131.5,131.3,131.1(d,J=8.6Hz),128.3(d,J=32.1,11.3Hz),115.1(d,J=21.3Hz),84.1,47.0(d,J=66.4Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ32.6. 19 F NMR(376MHz,CDCl 3 )δ-116.2.[α] D 20 =-53.3(c=1.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 27 H 30 BFO 3 PNa[M+Na] + :485.1828,found:485.1830.HPLC(AD-H,n-hexane/isopropanol=90/30,flow rate=1.0mL/min,l=220nm)tR=6.5min(minor),8.8min(major).
Figure BDA0004073659290000174
(1-(4-chlorophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)diphenylphosphine oxide(2c):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,91.9mg,96%yield,97%ee,yellow solid,m.p.179-180℃. 1 H NMR(400MHz,CDCl 3 )δ7.89-7.84(m,2H),7.53-7.42(m,5H),7.36-7.33(m,3H),7.29-7.25(m,2H),7.13(d,J=8.4Hz,2H),6.64-6.63(m,1H),6.10-6.09(m,1H),4.60(d,J=7.6Hz,1H),1.15(s,6H),1.09(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ136.1(d,J=9.0Hz),135.5(d,J=5.2Hz),133.6(d,J=9.5Hz),132.7,132.6(d,J=9.5Hz),131.6,131.5,131.41,131.37,131.1(d,J=8.6Hz),128.40,128.39(dd,J=25.8,11.7Hz),84.1,47.1(d,J=66.2Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ32.0.[α] D 20 =-70.0(c=1.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 27 H 30 BClO 3 P[M+H] + :479.1713,found:479.1704.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=16.2min(minor),39.9min(major).
Figure BDA0004073659290000181
(1-(4-bromophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)diphenylphosphine oxide(2d):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,103.6mg,99%yield,96%ee,white solid,m.p.183-184℃. 1 H NMR(400MHz,CDCl 3 )δ7.86-7.81(m,2H),7.51-7.40(m,5H),7.33(t,J=7.2Hz,1H),7.26-7.14(m,6H),6.61(br,1H),6.08-6.07(m,1H),4.58(d,J=6.8Hz,1H),1.13(s,6H),1.07(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ136.13(d,J=3.7Hz),136.06,133.5(d,J=7.7Hz),132.5(d,J=7.9Hz),131.8(d,J=6.6Hz),131.55,131.46,131.3,131.1(d,J=8.7Hz),128.4(d,J=23.9,11.5Hz),120.9(d,J=1.5Hz),84.1,47.1(d,J=66.0Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ32.2.[α] D 20 =-75.0(c=2.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 27 H 29 BBrO 3 PNa[M+Na] + :547.1011,found:547.1010.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=17.0min(minor),50.5min(major).
Figure BDA0004073659290000182
diphenyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(p-tolyl)allyl)phosphine oxide(2e):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,69.7mg,76%yield,98%ee,white solid,m.p.155-156℃. 1 H NMR(400MHz,CDCl 3 )δ7.89-7.85(m,2H),7.56-7.40(m,5H),7.34-7.31(m,3H),7.27-7.23(m,2H),6.97(d,J=8.0Hz,2H),6.65-6.63(m,1H),6.10-6.08(m,1H),4.63(d,J=7.6Hz,1H),2.24(s,3H),1.15(s,6H),1.10(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ136.3,135.9(d,J=9.3Hz),133.8(d,J=4.7Hz),132.8(d,J=2.1Hz),131.37(dd,J=38.5,8.8Hz),131.35(d,J=1.3Hz),129.9(d,J=6.7Hz),129.0,128.4(d,J=11.5Hz),128.1(d,J=11.5Hz),84.0,47.0(d,J=66.7Hz),24.9,24.6,21.1. 31 P NMR(162MHz,CDCl 3 )δ32.3.[α] D 20 =-160.0(c=1.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 28 H 33 BO 3 P[M+H] + :459.2260,found:459.2263.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=14.0min(minor),46.1min(major).
Figure BDA0004073659290000183
(1-(4-methoxyphenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)diphenylphosphine oxide(2f):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,85.4 mg,90%yield,97%ee,white solid,m.p.156-157℃. 1 H NMR(400MHz,CDCl 3 )δ7.89-7.85(m,2H),7.52-7.41(m,5H),7.35-7.31(m,3H),7.27-7.24(m,2H),6.71(d,J=8.4Hz,2H),6.63-6.61(m,1H),6.08-6.07(m,1H),4.59(d,J=7.6Hz,1H),3.72(s,3H),1.15(s,6H),1.09(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ158.4,135.5(d,J=9.2Hz),133.9(d,J=9.4Hz),133.0(d,J=8.1Hz),131.6(d,J=8.6Hz),131.4,131.2,131.1,128.8(d,J=4.9Hz),128.3(d,J=30.9,11.3Hz),113.7,84.0,55.2,46.7(d,J=66.8Hz),24.9,24.7. 31 PNMR(162MHz,CDCl 3 )δ32.8.[α] D 20 =-100.0(c=1.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 28 H 33 BO 4 P[M+H] + :475.2210,found:475.2210.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=20.7min(minor),54.5min(major).
Figure BDA0004073659290000191
diphenyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(4-(trifluoromethoxy)phen-yl)ally-l)phosp hine oxide(2g):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,88.8mg,84%yield,96%ee,white solid,m.p.142-143℃. 1 H NMR(400MHz,CDCl 3 )δ7.90-7.86(m,2H),7.51-7.45(m,5H),7.40(d,J=8.4Hz,2H),7.36-7.32(m,1H),7.27-7.23(m,2H),7.00(d,J=8.4Hz,2H),6.67-6.66(m,1H),6.11-6.10(m,1H),4.62(d,J=7.2Hz,1H),1.16(s,6H),1.09(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ148.2,136.0(d,J=8.8Hz),135.6(d,J=4.9Hz),133.5(d,J=24.5Hz),132.5(d,J=24.0Hz),131.6,131.53,131.48,131.4,131.1(d,J=8.5Hz),128.4(dd,J=34.7,11.3Hz),121.8,120.6,119.2,84.1,47.2(d,J=66.1Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ32.2. 19 F NMR(376MHz,CDCl 3 )δ-57.9.[α] D 20 =-100.0(c=1.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 28 H 29 BF 3 O 4 PNa[M+Na] + :551.1746,found:551.1749.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=13.0min(minor),39.8min(major).
Figure BDA0004073659290000192
methyl 4-(1-(diphenylphosphoryl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)benzoate(2h):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,90.4mg,90%yield,77%ee,white solid,m.p.173-174℃. 1 H NMR(400MHz,CDCl 3 )δ7.90-7.85(m,2H),7.83(d,J=8.0Hz,2H),7.51-7.43(m,7H),7.35-7.31(m,1H),7.26-7.22(m,2H),6.69-6.68(m,1H),6.13-6.11(m,1H),4.68(d,J=7.2Hz,1H),3.85(s,3H),1.14(s,6H),1.09(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ167.2,142.5(d,J=4.9Hz),136.4(d,J=8.9Hz),133.4(d,J=5.4Hz),132.5(d,J=5.4Hz),131.6,131.5,131.4(d,J=1.4Hz),131.1(d,J=8.8Hz),130.2(d,J=6.2Hz),129.5,128.4(dd,J=28.9,11.4Hz),84.1,52.1,47.9(d,J=65.4Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ31.4.[α] D 20 =-20.0(c=2.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 29 H 32 BO 5 PNa[M+Na] + :525.1978,found:525.1975.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=25.1min(minor),51.2min(major).
Figure BDA0004073659290000193
diphenyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(4-(trifluoromethyl)phenyl)allyl)-phosphi ne oxide(2i):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,92.2 mg,90%yield,83%ee,white solid,m.p.149-150℃. 1 H NMR(400MHz,CDCl 3 )δ7.90-7.85(m,2H),7.54-7.45(m,7H),7.41(d,J=8.4Hz,2H),7.34(t,J=6.8Hz,1H),7.28-7.25(m,2H),6.69-6.67(m,1H),6.14-6.12(m,1H),4.69(d,J=7.6Hz,1H),1.15(s,6H),1.10(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ141.2(d,J=4.4Hz),136.5(d,J=8.7Hz),133.3(d,J=9.1Hz),132.4(d,J=9.9Hz),131.65,131.56,131.5,131.0(d,J=8.6Hz),130.4(d,J=6.3Hz),128.5(dd,J=26.2,11.5Hz),125.1(d,J=3.5Hz),84.2,47.6(d,J=65.7Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ32.0. 19 F NMR(376MHz,CDCl 3 )δ-62.5.[α] D 20 =-90.0(c=2.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 28 H 29 BF 3 O 3 PNa[M+Na] + :535.1797,found:535.1791.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=12.9min(minor),29.6min(major).
Figure BDA0004073659290000201
4-(1-(diphenylphosphoryl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)benzonitrile(2j):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,71.3mg,76%yield,66%ee,white solid,m.p.172-173℃. 1 H NMR(400MHz,CDCl 3 )δ7.89-7.84(m,2H),7.50-7.43(m,9H),7.38-7.34(m,1H),7.29-7.25(m,2H),6.68-6.67(m,1H),6.14-6.12(m,1H),4.65(d,J=7.6Hz,1H),1.15(s,6H),1.08(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ142.6(d,J=5.4Hz),136.6(d,J=8.9Hz),133.0(d,J=22.1Hz),132.2,131.9,131.7(dd,J=18.1,1.4Hz),131.4(d,J=8.8Hz),130.9(d,J=18.0Hz),130.87(d,J=2.5Hz),128.5(dd,J=26.0,11.6Hz),119.0,110.6,84.2,48.0(d,J=64.9Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ31.3.[α] D 20 =-112.0(c=2.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 28 H 30 BNO 3 P[M+H] + :470.2056,found:470.2052.HPLC(AD-H,n-hexane/isopropanol=70/30,flow rate=1.0mL/min,l=220nm)tR=8.0min(minor),15.9min(major).
Figure BDA0004073659290000202
(1-(3-chloro-4-fluorophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)diphenylphosphine oxide(2k):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,98.4mg,99%yield,95%ee,white solid,m.p.159-160℃. 1 H NMR(400MHz,CDCl 3 )δ7.85(dd,J=10.8,7.2Hz,2H),7.53-7.43(m,5H),7.38-7.26(m,5H),6.93(t,J=8.8Hz,1H),6.64(br,1H),6.11-6.10(m,1H),4.56(d,J=4.0Hz,1H),1.16(s,6H),1.11(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ157.2(d,J=249.1Hz),136.3(d,J=8.1Hz),134.0,133.3(d,J=16.6Hz),132.4(d,J=17.4Hz),132.1(d,J=5.9Hz),131.55(d,J=19.3Hz),131.53,131.1(d,J=8.3Hz),129.9,129.81,129.75,128.5(dd,J=23.4,11.4Hz),120.4(d,J=17.8Hz),116.2(d,J=21.0Hz),84.2,46.9(d,J=64.1Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ31.4. 19 F NMR(376MHz,CDCl 3 )δ-118.4.[α] D 20 =-45.0(c=2.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 27 H 29 BClFO 3 P[M+H] + :497.1619,found:497.1621.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=14.2min(minor),22.2min(major).
Figure BDA0004073659290000203
(1-(3-methoxyphenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)diphenylphosphine oxide(2l):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,76.8mg,81%yield,93%ee,white solid,m.p.81-82℃. 1 H NMR(400MHz,CDCl 3 )δ7.89-7.85(m,2H),7.56-7.51(m,2H),7.48-7.41(m,3H),7.34-7.31(m,1H),7.27-7.23(m,2H),7.09-6.99(m,3H),6.69-6.65(m,2H),6.11(dd,J=3.2,2.4Hz,1H),4.61(d,J=7.6Hz,1H),3.68(s,3H),1.15(s,6H),1.10(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ159.3,138.5(d,J=4.9Hz),136.0(d,J=8.9Hz),133.9(d,J=5.6Hz),132.9(d,J=5.4Hz),131.6(d,J=8.7Hz),131.4,131.22,131.17,131.1,129.1,128.3(dd,J=29.8,11.5Hz),122.6(d,J=6.8Hz),115.2(d,J=6.8Hz),112.9,84.0,55.2,47.5(d,J=66.4Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ32.9.[α] D 20 =-63.6(c=2.2,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 28 H 32 BO 4 PNa[M+Na] + :497.2028,found:497.2023.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=23.4min(minor),49.1min(major).
Figure BDA0004073659290000211
(1-(2-chlorophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)diphenylphosphine oxide(2m):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,50.7mg,53%yield,76%ee,white oil. 1 H NMR(400MHz,CDCl 3 )δ8.21(d,J=7.6Hz,1H),7.88-7.83(m,2H),7.61-7.57(m,2H),7.49-7.42(m,3H),7.36-7.33(m,1H),7.28-7.25(m,2H),7.20-7.14(m,2H),7.05(t,J=7.6Hz,1H),6.46-6.44(m,1H),6.18(dd,J=4.0,2.0Hz,1H),5.32(d,J=8.0Hz,1H),1.08(s,6H),1.03(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ137.3(d,J=8.5Hz),136.1,134.1(d,J=9.1Hz),133.5(d,J=9.2Hz),132.5(d,J=7.5Hz),132.0,131.9,131.4(d,J=4.0Hz),131.1(d,J=8.8Hz),129.2,128.3(dd,J=11.5,5.1Hz),128.0,127.0,83.9,43.0(d,J=66.9Hz),25.2,24.2. 31 P NMR(162MHz,CDCl 3 )δ32.0.[α] D 20 =+40.0(c=2.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 27 H 29 BClO 3 PNa[M+Na] + :501.1533,found:501.1532.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=20.4min(minor),31.6min(major).
Figure BDA0004073659290000212
(1-(2-iodophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)diphenylphosphine oxide(2n):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,58.2mg,51%yield,89%ee,white solid,m.p.137-138℃. 1 H NMR(400MHz,CDCl 3 )δ8.22(d,J=7.6Hz,1H),7.90-7.86(m,2H),7.68(d,J=7.6Hz,1H),7.56-7.45(m,5H),7.35(t,J=7.2Hz,1H),7.28-7.24(m,3H),6.81(t,J=7.6Hz,1H),6.44(br,1H),6.20(br,1H),5.13(d,J=8.4Hz,1H),1.08(s,6H),1.05(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ140.8,139.5,137.2(d,J=8.5Hz),132.3(d,J=9.9Hz),132.0(d,J=8.7Hz),131.8(d,J=4.3Hz),131.5,131.4,131.3,128.5,128.4,128.3,128.2,103.1(d,J=10.4Hz),83.9,51.2(d,J=65.4Hz),25.3,24.3. 31 P NMR(162MHz,CDCl 3 )δ32.3.[α] D 20 =+32.0(c=2.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 27 H 29 BIO 3 PNa[M+Na] + :593.0889,found:593.0887.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=13.6min(minor),19.8min(major).
Figure BDA0004073659290000213
(1-(naphthalen-1-yl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)diphenylphosphine oxide(2o):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,59.3mg,60%yield,44%ee,white solid,m.p.154-155℃. 1 H NMR(400MHz,CDCl 3 )δ8.46(d,J=5.6Hz,1H),8.35(d,J=8.0Hz,1H),7.85-7.78(m,3H),7.66-7.64(m,3H),7.48-7.44(m,5H),7.35(t,J=6.8,1H),7.27-7.24(m,1H),7.19-7.17(m,2H),6.45(br,1H),6.23(br,1H),5.52(d,J=8.0Hz,1H),1.09(s,6H),1.07(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ138.3(d,J=5.8Hz),135.7,134.0,132.1(d,J=8.1Hz),131.8(d,J=8.2Hz),131.3(d,J=2.3Hz),131.1(d,J=7.6Hz),129.0,128.4,128.3,128.2,128.0(d,J=4.4Hz),127.3,125.9,125.7(d,J=54.8Hz),84.0,41.7(d,J=63.8Hz),25.3,24.2. 31 P NMR(162MHz,CDCl 3 )δ32.3.[α] D 20 =+26.9(c=2.6,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 31 H 32 BO 3 PNa[M+Na] + :517.2080,found:517.2081.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=23.8min(minor),29.2min(major).
Figure BDA0004073659290000214
diphenyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(thiophen-3-yl)allyl)phosphine oxide(2p):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,85.6mg,95%yield,94%ee,white solid,m.p.144-145℃. 1 H NMR(400MHz,CDCl 3 )δ7.84(t,J=8.4Hz,2H),7.57(m,2H),7.49-7.39(m,3H),7.36(d,J=7.2Hz,1H),7.31-7.26(m,3H),7.14-7.12(m,1H),7.06(d,J=4.8Hz,1H),6.56(br,1H),6.14-6.13(m,1H),4.84(d,J=7.2Hz,1H),1.15(s,6H),1.10(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ136.7(d,J=5.8Hz),136.3(d,J=8.8Hz),133.7(d,J=34.9Hz),132.7(d,J=34.8Hz),131.4(dd,J=53.8,8.8Hz),131.37(dd,J=15.4,1.2Hz),129.2(d,J=5.5Hz),128.3(dd,J=20.0,10.5Hz),124.9,123.7(d,J=7.7Hz),84.0,43.1(d,J=66.9Hz),24.9,24.7. 31 P NMR(162MHz,CDCl 3 )δ32.1.[α] D 20 =-66.7(c=1.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 25 H 29 BO 3 PS[M+H] + :451.1667,found:451.1666.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=16.0min(minor),20.3min(major).
Figure BDA0004073659290000221
diphenyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(thiophen-2-yl)allyl)phosphine oxide(2q):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,76.5mg,85%yield,81%ee,brown solid,m.p.148-149℃. 1 H NMR(400MHz,CDCl 3 )δ7.87-7.82(m,2H),7.68-7.63(m,2H),7.48-7.38(m,4H),7.35-7.31(m,2H),7.07-7.06(m,2H),6.82(t,J=4.4Hz,1H),6.64-6.62(m,1H),6.19-6.18(m,1H),4.97(d,J=8.8Hz,1H),1.15(s,6H),1.11(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ139.0(d,J=5.8Hz),136.9(d,J=8.5Hz),133.3(d,J=7.9Hz),132.3(d,J=7.4Hz),131.5(dd,J=43.0,8.8Hz),131.3(dd,J=7.7,1.8Hz),128.3(dd,J=14.4,11.8Hz),127.3(d,J=6.5Hz),126.8,124.7(d,J=1.1Hz),84.1,42.5(d,J=66.2Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ30.9.[α] D 20 =-66.7(c=1.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 25 H 28 BO 3 PSNa[M+Na] + :473.1482,found:473.1452.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=21.1min(minor),29.0min(major).
Figure BDA0004073659290000222
diphenyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-yl)phosphine oxide(2r):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,52mg,68%yield,79%ee,white oil. 1 H NMR(400MHz,CDCl 3 )δ7.89-7.84(m,2H),7.76-7.71(m,2H),7.47-7.44(m,3H),7.42-7.33(m,3H),6.23-6.21(m,1H),6.11-6.09(m,1H),3.53-3.46(m,1H),1.32(dd,J=16.4,7.6Hz,3H),1.11(s,6H),1.08(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ134.9(d,J=8.7Hz),133.6(d,J=37.7Hz),132.6(d,J=33.8Hz),131.45(dd,J=27.1,8.8Hz),131.35(dd,J=24.6,1.4Hz),128.4(dd,J=35.8,11.0Hz),83.8,35.0(d,J=67.4Hz),24.9,24.7,15.1(d,J=2.4Hz). 31 P NMR(162MHz,CDCl 3 )δ34.1.[α] D 20 =+32.0(c=2.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 22 H 29 BO 3 P[M+H] + :383.1946,found:383.1944.HPLC(IC,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=31.3min(minor),39.3 min(major).
Figure BDA0004073659290000223
bis(4-fluorophenyl)(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)phosphine oxide(4a):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,79.7mg,83%yield,96%ee,white oil. 1 H NMR(400MHz,CDCl 3 )δ7.90-7.83(m,2H),7.49-7.43(m,2H),7.39-7.37(m,2H),7.20-7.12(m,5H),6.94(dt,J=8.6,2.0Hz,2H),6.65-6.64(m,1H),6.12-6.11(m,1H),4.55(d,J=7.6Hz,1H),1.16(s,6H),1.11(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ136.5(d,J=5.6Hz),136.2(d,J=9.4Hz),134.1,134.0,133.9,133.7,133.6,133.5,130.1(d,J=6.8Hz),128.4,127.0,116.1,115.94,115.85,115.7,115.6,115.5,115.4,84.1,47.9(d,J=67.4Hz),24.9,24.6. 31 P NMR(162MHz,CDCl 3 )δ31.3. 19 F NMR(376MHz,CDCl 3 )δ-107.5,-107.6.[α] D 20 =-60.0(c=1.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 27 H 29 BF 2 O 3 P[M+H] + :481.1915,found:481.1918.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=12.1min(minor),26.5min(major).
Figure BDA0004073659290000231
bis(3,5-dimethylphenyl)(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)phosphine oxide(4b):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,79.1mg,79%yield,92%ee,whitesolid,m.p.77-78℃. 1 H NMR(400MHz,CDCl 3 )δ7.46(d,J=11.2Hz,2H),7.39(d,J=8.0Hz,2H),7.18-7.09(m,4H),7.03(d,J=11.6Hz,2H),6.92(s,1H),6.67(br,1H),6.10(t,J=2.8Hz,1H),4.55(d,J=7.6Hz,1H),2.34(s,6H),2.16(s,6H),1.16(s,6H),1.09(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ137.7(dd,J=42.2,12.0Hz),137.2(d,J=5.1Hz),135.7(d,J=9.0Hz),133.6(d,J=15.2Hz),133.0(dd,J=30.9,2.3Hz),132.7(d,J=14.4Hz),130.2(d,J=6.5Hz),129.0(dd,J=35.5,8.8Hz),128.1,126.6,83.9,47.7(d,J=65.8Hz),25.0,24.4,21.5,21.3. 31 P NMR(162MHz,CDCl 3 )δ33.2.[α] D 20 =-80.0(c=2.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 31 H 39 BO 3 P[M+H] + :501.2730,found:501.2725.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=6.5min(minor),10.4min(major).
Figure BDA0004073659290000232
(1-(4-bromophenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)bis(3,5-dimet-hylphe-nyl)ph osphine oxide(4c):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,76.5mg,66%yield,96%ee,green solid,m.p.79-80℃. 1 H NMR(400MHz,CDCl 3 )δ7.41(d,J=11.2Hz,2H),7.28-7.26(m,2H),7.25-7.22(m,2H),7.08(s,1H),7.02(d,J=11.6Hz,2H),6.94(s,1H),6.63(br,1H),6.08(t,J=2.8Hz,1H),4.48(d,J=7.6Hz,1H),2.32(s,6H),2.18(s,6H),1.15(s,6H),1.08(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ137.9(dd,J=31.5,12.2Hz),136.3(d,J=5.1Hz),136.0(d,J=9.2Hz),133.25(d,J=20.0Hz),133.18(dd,J=22.2,2.4Hz),132.3(d,J=20.2Hz),131.9(d,J=6.5Hz),131.2,128.9(dd,J=39.3,8.9Hz),120.8,84.0,47.1(d,J=65.5Hz),25.0,24.5,21.5,21.4. 31 P NMR(162MHz,CDCl 3 )δ32.9.[α] D 20 =-77.3(c=2.2,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 31 H 38 BBrO 3 P[M+H] + :579.1835,found:579.1830.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=7.0min(minor),14.0min(major).
Figure BDA0004073659290000233
bis(3-methoxyphenyl)(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(p-tolyl)allyl)phosphine oxide(4d):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,55mg,53%yield,94%ee,white solid,m.p.71-72℃. 1 H NMR(400MHz,CDCl 3 )δ7.44-7.30(m,5H),7.17(dt,J=8.0,4.0Hz,1H),7.07-6.98(m,5H),6.86(dd,J=8.0,2.0Hz,1H),6.64(br,1H),6.08(dd,J=3.2,2.4Hz,1H),4.55(d,J=8.0Hz,1H),3.82(s,3H),3.62(s,3H),2.25(s,3H),1.15(s,6H),1.10(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ159.3(dd,J=45.7,14.0Hz),136.6(d,J=50.4Hz),135.6(d,J=9.5Hz),135.1(d,J=24.5Hz),134.2(d,J=23.9Hz),133.9(d,J=5.7Hz),130.0(d,J=6.7Hz),129.4(dd,J=31.2,13.8Hz),129.0,123.4(dd,J=38.2,9.1Hz),117.7,116.3(dd,J=59.8,9.2Hz),84.0,55.4(d,J=19.5Hz),47.2(d,J=66.8Hz),25.0,24.6,21.1. 31 P NMR(162MHz,CDCl 3 )δ32.9.[α] D 20 =-40.9(c=2.2,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 30 H 37 BO 5 P[M+H] + :519.2472,found:519.2471.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=22.8min(minor),53.6min(major).
Figure BDA0004073659290000241
bis(2-methoxyphenyl)(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)phosphine oxide(4e):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,55.5mg,55%yield,88%ee,white solid,m.p.81-82℃. 1 H NMR(400MHz,CDCl 3 )δ7.91(ddd,J=12.8,7.6,1.2Hz,1H),7.58(ddd,J=12.4,7.6,1.2Hz,1H),7.44(d,J=7.6Hz,2H),7.40-7.36(m,1H),7.26-7.22(m,1H),7.13-7.09(m,2H),7.06-6.97(m,2H),6.81-6.77(m,2H),6.67-6.64(m,2H),6.05-6.03(m,1H),5.10(d,J=10.0Hz,1H),3.67(s,3H),3.53(s,3H),1.17(s,6H),1.08(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ160.3(dd,J=67.3,3.3Hz),138.4(d,J=5.2Hz),134.5(dd,J=12.5,9.8Hz),134.2(d,J=6.1Hz),132.8,132.6(d,J=1.0Hz),130.2(d,J=7.0Hz),127.8,126.2,123.0,122.0,120.3(d,J=11.2Hz),110.8(dd,J=33.6,6.7Hz),83.6,55.3(d,J=8.3Hz),46.8(d,J=70.1Hz),25.2,24.4. 31 PNMR(162MHz,CDCl 3 )δ31.1.[α] D 20 =-66.7(c=1.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 29 H 35 BO 5 P[M+H] + :505.2315,found:505.2323.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=21.8min(minor),33.5min(major).
Figure BDA0004073659290000242
(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)di-o-tolylphosphine oxide(4f):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,47.2mg,50%yield,78%ee,yellow solid,m.p.75-76℃. 1 H NMR(400MHz,CDCl 3 )δ7.80(dd,J=12.0,7.2Hz,1H),7.41-7.39(m,2H),7.36-7.29(m,2H),7.27-7.11(m,6H),7.01-6.95(m,2H),6.73(br,1H),6.20(t,J=3.0Hz,1H),4.66(d,J=7.6Hz,1H),2.33(s,3H),2.09(s,3H),1.15(s,6H),1.06(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ142.8(d,J=46.2,7.4Hz),137.6(d,J=4.9Hz),136.5(d,J=8.6Hz),133.1(d,J=10.3Hz),132.4(d,J=24.8Hz),132.0(dd,J=13.3,11.8Hz),131.5(d,J=10.6Hz),131.2(dd,J=26.4,2.0Hz),130.4(d,J=6.4Hz),128.2,126.6,125.0(dd,J=1.3Hz),124.9(d,J=2.4Hz),83.9,47.0(d,J=66.2Hz),25.0,24.4,21.5(d,J=3.7Hz),20.9(d,J=3.2Hz). 31 P NMR(162MHz,CDCl 3 )δ37.0.[α] D 20 =-34.6(c=2.6,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 29 H 35 BO 3 P[M+H] + :473.2416,found:473.2421.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=7.3min(minor),9.3min(major).
Figure BDA0004073659290000243
dicyclohexyl(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)phosphine oxide(4g):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=2:1)as eluent,59.3mg,65%yield,80%ee,viscous oil. 1 H NMR(400MHz,CDCl 3 )δ7.54(d,J=8.0Hz,2H),7.29-7.25(m,2H),7.22-7.18(m,1H),6.72(t,J=2.0Hz,1H),6.12(t,J=2.8Hz,1H),3.97(d,J=5.6Hz,1H),2.11-1.81(m,9H),1.72-1.56(m,5H),1.43-1.32(m,3H),1.22(s,12H),1.07-0.85(m,5H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ139.1(d,J=5.2Hz),135.5(d,J=7.1Hz),129.8(d,J=6.1Hz),129.2(d,J=16.7Hz),128.6,126.7,84.0,42.9(d,J=55.1Hz),38.3(dd,J=61.3,9.9Hz),27.5,27.37,27.35,27.22,27.16,27.13,27.11,27.10,27.04,26.97,26.9(d,J=2.2Hz),26.4(d,J=1.0Hz),26.2,25.0,24.8. 31 P NMR(162MHz,CDCl 3 )δ52.2.[α] D 20 =-100.0(c=1.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 27 H 43 BO 3 P[M+H] + :457.3042,found:457.3052.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=8.5min(major),21.0min(minor).
Figure BDA0004073659290000251
diisobutyl(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)phosphine oxide(4h):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=2:1)as eluent,42.9mg,53%yield,86%ee,white solid,m.p.76-77℃. 1 H NMR(400MHz,CDCl 3 )δ7.49-7.47(m,2H),7.30-7.26(m,2H),7.23-7.19(m,1H),6.53(br,1H),6.14(t,J=2.8Hz,1H),3.78(d,J=8.8Hz,1H),2.19-2.00(m,2H),1.83-1.62(m,2H),1.55-1.41(m,2H),1.21(s,6H),1.19(s,6H),1.06-1.02(m,6H),0.87(d,J=11.6,6.4Hz,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ138.0(d,J=4.8Hz),134.5(d,J=8.3Hz),129.9(d,J=6.4Hz),129.3(d,J=103.7Hz),128.5,126.8,84.0,49.6(d,J=59.4Hz),37.5(dd,J=62.4,43.3Hz),25.2(dd,J=16.2,9.6Hz),24.9,24.7,24.5(dd,J=14.8,7.0Hz),23.9(dd,J=31.4,3.7Hz). 31 P NMR(162MHz,CDCl 3 )δ48.0.[α] D 20 =-45.5(c=2.2,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 23 H 39 BO 3 P[M+H] + :405.2730,found:405.2727.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=13.2min(minor),15.5min(major).
Figure BDA0004073659290000252
Dimethyl(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)phosphonate(4i):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=2:1)as eluent,32mg,45%yield,94%ee,green oil. 1 H NMR(400MHz,CDCl 3 )δ7.44-7.42(m,2H),7.31-7.26(m,2H),7.24-7.20(m,1H),6.28-6.27(m,1H),6.12-6.10(m,1H),4.24(d,J=24.0Hz,1H),3.71(d,J=11.2Hz,3H),3.51(d,J=10.4Hz,3H),1.20(s,6H),1.14(s,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ136.0(d,J=5.6Hz),133.0(d,J=10.0Hz),130.0(d,J=7.6Hz),129.0(d,J=22.4Hz),128.4,127.1(d,J=1.3Hz),84.0,53.4(d,J=6.9Hz),53.1(d,J=7.0Hz),46.8(d,J=137.6Hz),24.9,24.6. 31 PNMR(162MHz,CDCl 3 )δ29.1.[α] D 20 =-55.6(c=1.8,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 17 H 26 BO 5 PNa[M+Na] + :375.1506,found:375.1505.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=5.5min(minor),6.6min(major).
Figure BDA0004073659290000253
diethyl(1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)phosphonate(4j):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=2:1)as eluent,66.9mg,88%yield,95%ee,white oil. 1 H NMR(400MHz,CDCl 3 )δ7.44-7.42(m,2H),7.28-7.24(m,2H),7.21-7.17(m,1H),6.33-6.32(m,1H),6.10(dd,J=3.6,2.4Hz,2H),4.19(d,J=23.6Hz,1H),4.09-4.01(m,2H),3.94-3.86(m,1H),3.81-3.72(m,1H),1.26(t,J=7.2Hz,3H),1.19(s,6H),1.12(s,6H),1.08(t,J=6.8Hz,3H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ136.4(d,J=5.8Hz),132.9(d,J=9.8Hz),130.0(d,J=7.6Hz),128.7,128.3,126.9(d,J=1.7Hz),83.9,62.5(d,J=6.9Hz),62.2(d,J=7.0Hz),47.1(d,J=137.3Hz),24.9,24.5,16.5(d,J=6.0Hz),16.3(d,J=5.9Hz). 31 P NMR(162MHz,CDCl 3 )δ26.7.[α] D 20 =-28.0(c=2.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 19 H 31 BO 5 P[M+H] + :381.2002,found:381.2004.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=5.9min(minor),7.8min(major).
Figure BDA0004073659290000254
(4k):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=2:1)as eluent,54.7mg,63%yield,59%ee,white oil. 1 H NMR(400MHz,CDCl 3 )δ7.51-7.49(m,2H),7.23-7.19(m,2H),7.15-7.11(m,1H),6.78-6.77(m,1H),6.07-6.05(m,1H),4.08(d,J=13.6Hz,1H),3.08-2.98(m,4H),2.75-2.67(m,4H),1.18(s,6H),1.15(s,6H),1.08(t,J=7.2Hz,6H),0.76(t,J=7.2Hz,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ138.9(d,J=4.7Hz),134.0(d,J=8.0Hz),130.3(d,J=6.9Hz),128.8,128.0,126.3,83.8,45.1(d,J=109.5Hz),39.5(d,J=3.6Hz),38.9(d,J=3.4Hz),25.0,24.6,14.5,14.3. 31 P NMR(162MHz,CDCl 3 )δ34.0.[α] D 20 =-66.7(c=1.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 23 H 40 BN 2 O 3 PNa[M+Na] + :457.2766,found:457.2762.HPLC(IC,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=10.7min(minor),11.5min(major).
application example
The present application example performed a series of transformations on compound 2a according to the general scheme of the reaction shown in formula 10, and found that the derivatization reaction shown in formula 10 was performed smoothly and a corresponding product with a retained configuration was obtained. The palladium-catalyzed Suzuki coupling gave product 5 in 92% yield and 97% ee value. On CH 3 B(OH) 2 Hydrolysis of 2a under HCl conditions gives the corresponding boronic acid compound 6 in 63% yield and 97% ee. FIG. 2 shows a single crystal diffraction structure of Compound 6. Chiral centers of Compound 6 were defined as R configuration by X-ray diffraction analysis. Under the action of copper (II) halide, the aqueous methanol is used as a solvent to obtain chloro and bromo products 7 and 8 in high yield. Under the aerobic condition, the 2a boron removal reaction catalyzed by silver is smoothly carried out.
Figure BDA0004073659290000261
(1) A specific preparation method of the product 5 in the formula 10:
Figure BDA0004073659290000262
according to the reaction scheme shown in formula 11, a 25mL Schlenk tube was charged with magneton, evacuated and replaced with nitrogen, and repeated three times, while adding tetrakis triphenylphosphine palladium (5 mol%), cesium fluoride (2 equiv), 2a (0.1 mmol) and methyl p-iodobenzoate (0.12 mmol) under nitrogen atmosphere, 1.4-dioxane (2 mL)/water (0.1 mL) was added as a solvent, and the reaction was stirred at 90℃overnight. After completion of the reaction, the reaction was quenched with saturated sodium chloride (5 mL), allowed to stand for separation, the organic phase was separated with a separating funnel, and the aqueous phase was extracted with ethyl acetate (5 ml×3), the organic phases were combined, and finally dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporator and the crude product was separated by column chromatography (petroleum ether: ethyl acetate=1:1, v: v) to give the desired product 5.
(2) A specific preparation method of the product 6 in the formula 10:
Figure BDA0004073659290000263
according to the reaction scheme shown in formula 12, a 25mL Schlenk tube was charged with magneton, evacuated and replaced with nitrogen, and repeated three times, 2a (88.9 mg,0.2mmol,1.0 equiv), methylboronic acid (5-10 equiv) and hydrochloric acid/acetone (1 mL/1 mL) were sequentially added. The reaction was stirred at room temperature, after completion of the reaction, deionized water was added, allowed to stand for separation, the organic phase was separated with a separating funnel, and the aqueous phase was extracted with ethyl acetate (5 ml×3), the organic phases were combined, and finally dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporator and the crude product was isolated by column chromatography (petroleum ether: ethyl acetate=1:1, v: v) to give the product, which was then recrystallized from ethyl acetate and petroleum ether to give pure target product 6.
(3) Specific preparation methods of products 7 and 8 in formula 10:
Figure BDA0004073659290000264
/>
according to the reaction scheme shown in formula 13, a 25mL Schlenk tube was charged with magneton, 2a (88.9 mg,0.2 mmol), copper halide (0.6 mmol, X=Cl or Br) and methanol/water (1 mL/1 mL) were sequentially added, and the reaction was stirred at 80℃for 6 hours. After the reaction was completed, the reaction was quenched with saturated sodium chloride solution (1 mL), allowed to stand for delamination, the organic phase was separated with a separating funnel, and the aqueous phase was extracted with ethyl acetate (5 ml×3), the organic phases were combined, and finally dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporator and the crude product was separated by column chromatography (petroleum ether: ethyl acetate=1:1, v: v) to give the desired products 7 and 8.
(3) A specific preparation method of the product 9 in the formula 10:
Figure BDA0004073659290000271
according to the reaction scheme shown in formula 14, a 25mL Schlenk tube was charged with magneton, and 2a (88.9 mg,0.2 mmol), silver nitrate (2.0 mg,6 mol%), triethylamine (20.2 mg,0.2 mmol) and ethanol/water (1 mL/1 mL) were sequentially added, and the reaction was stirred at 80℃for 3 hours. After the reaction was completed, the reaction was quenched with saturated sodium chloride solution (1 mL), allowed to stand for delamination, the organic phase was separated with a separating funnel, and the aqueous phase was extracted with ethyl acetate (5 ml×3), the organic phases were combined, and finally dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporator and the crude product was separated by column chromatography (petroleum ether: ethyl acetate=1:1, v: v) to give the desired product 9.
The structural characterization data of the compounds 5 to 9 prepared in the application example of the invention are specifically as follows:
Figure BDA0004073659290000272
methyl 4-(3-(diphenylphosphoryl)-3-phenylprop-1-en-2-yl)benzoate(5):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,41.6mg,92%yield,97%ee,yellow solid,m.p.183-184℃. 1 H NMR(400MHz,CDCl 3 )δ7.87(d,J=8.4Hz,2H),7.81-7.76(m,2H),7.51-7.47(m,1H),7.43-7.35(m,5H),7.31-7.29(m,2H),7.27-7.23(m,2H),7.20-7.18(m,5H),6.39(d,J=2.0Hz,1H),5.61(d,J=1.6Hz,1H),4.55(d,J=9.6Hz,1H),3.88(s,3H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ166.9,147.7(d,J=8.6Hz),143.6(d,J=3.4Hz),134.5(d,J=6.1Hz),133.0(d,J=7.1Hz),132.0(d,J=5.4Hz),131.7(dd,J=23.8,2.4Hz),131.3(dd,J=16.5,8.9Hz),130.2(d,J=5.4Hz),129.8,129.2,128.5,128.4(dd,J=43.4,11.7Hz),127.5(d,J=1.3Hz),126.3,121.4(d,J=7.1Hz),52.3,51.6. 31 P NMR(162MHz,CDCl 3 )δ32.5.[α] D 20 =-56.5(c=2.3,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 29 H 26 O 3 P[M+H] + :453.1614,found:453.1619.HPLC(IC,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=33.4min(major),37.6min(minor).
Figure BDA0004073659290000273
(3-(diphenylphosphoryl)-3-phenylprop-1-en-2-yl)boronic acid(6):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=5:1)as eluent,45.6mg,63%yield,97%ee,white solid,m.p.107-108℃. 1 H NMR(400MHz,CDCl 3 )δ7.85-7.80(m,2H),7.59-7.47(m,5H),7.41-7.28(m,7H),7.21-7.11(m,3H),5.76(t,J=2.3Hz,1H),5.44(t,J=3.0Hz,1H),4.35(d,J=8.8Hz,1H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ136.1(d,J=5.4Hz),132.9(d,J=12.2Hz),132.1(dd,J=17.4,2.0Hz),131.4(d,J=28.5,8.7Hz),130.7,129.9(d,J=51.0Hz),129.4(d,J=7.0Hz),128.9,128.6(dd,J=28.4,16.6Hz),127.2,57.3(d,J=64.1Hz). 31 P NMR(162MHz,CDCl 3 )δ37.8.[α] D 20 =-60.0(c=1.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 21 H 21 BO 3 P[M+H] + :363.1321,found:363.1319.HPLC(AD-H,n-hexane/ethanol=90/10,flow rate=1.0mL/min,l=220nm)tR=15.0min(minor),20.9min(major).
Figure BDA0004073659290000274
(2-chloro-1-phenylallyl)diphenylphosphine oxide(7):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,58.4mg,82%yield,97%ee,white solid,m.p.198-199℃. 1 H NMR(600MHz,CDCl 3 )δ7.97-7.93(m,2H),7.58-7.52(m,3H),7.37-7.32(m,3H),7.27-7.25(m,2H),7.23-7.17(m,5H),6.20(d,J=1.2Hz,1H),5.43(br,1H),4.30(d,J=9.6Hz,1H). 13 C{ 1 H}NMR(151MHz,CDCl 3 )δ137.5,132.9(d,J=5.0Hz),132.4(d,J=10.0Hz),132.1(d,J=2.9Hz),131.8(d,J=14.0Hz),131.7(d,J=2.7Hz),131.4(d,J=8.9Hz),131.2(d,J=8.9Hz),130.2(d,J=5.1Hz),128.9(d,J=11.6Hz),128.4(d,J=1.5Hz),128.2(d,J=11.9Hz),127.9(d,J=2.3Hz),118.7(d,J=4.7Hz),56.1(d,J=62.4Hz). 31 P NMR(162MHz,CDCl 3 )δ30.8.[α] D 20 =-340.0(c=1.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 21 H 19 ClOP[M+H] + :353.0857,found:353.0858.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=18.1min(minor),31.2min(major).
Figure BDA0004073659290000281
(2-bromo-1-phenylallyl)diphenylphosphine oxide(8):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,78.7mg,99%yield,99%ee,white solid,m.p.212-213℃. 1 H NMR(600MHz,CDCl 3 )δ7.98-7.95(m,2H),7.61-7.54(m,3H),7.36-6.29(m,3H),7.23-7.18(m,7H),6.69(br,1H),5.70(d,J=2.4Hz,1H),4.39(d,J=9.0Hz,1H). 13 C{ 1 H}NMR(151MHz,CDCl 3 )δ132.6(d,J=5.1Hz),132.3,132.2(d,J=2.4Hz),131.7(d,J=2.3Hz),131.6(d,J=11.6Hz),131.3(d,J=8.8Hz),131.0(d,J=9.1Hz),130.1(d,J=4.9Hz),129.0(d,J=11.5Hz),128.4(d,J=1.4Hz),128.2(d,J=11.9Hz),127.9(d,J=1.8Hz),127.6,123.4(d,J=4.8Hz),57.9(d,J=59.9Hz). 31 P NMR(162MHz,CDCl 3 )δ31.6.[α] D 20 =-185.0(c=2.0,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 21 H 19 BrOP[M+H] + :397.0351,found:397.0352.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=17.1min(minor),30.5min(major).
Figure BDA0004073659290000282
diphenyl(1-phenylallyl)phosphine oxide(9):Purified by column chromatography on silica gel with petroleum ether/EtOAc(v/v=1:1)as eluent,41.3mg,65%yield,86%ee,white solid,m.p.180-181℃. 1 H NMR(400MHz,CDCl 3 )δ7.89-7.84(m,2H),7.55-7.47(m,5H),7.37-7.34(m,1H),7.30-7.24(m,4H),7.22-7.14(m,3H),6.29-6.18(m,1H),5.15(dd,J=10.0,2.8Hz,1H),5.04(dd,J=16.8,4.0Hz,1H),4.24(t,J=9.2Hz,1H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ135.5(d,J=6.2Hz),133.0(d,J=6.8Hz),131.7(dd,J=31.6,8.6Hz),131.6(d,J=138.2Hz),131.5(dd,J=49.1,2.7Hz),129.5(d,J=5.8Hz),128.6,128.4(dd,J=33.6,11.7Hz),127.2(d,J=2.0Hz),119.8(d,J=11.0Hz),52.9(d,J=65.1Hz). 31 P NMR(162MHz,CDCl 3 )δ31.8.[α] D 20 =-48.0(c=2.5,CHCl 3 ).HRMS(ESI-MS)m/z calcd.for C 21 H 20 OP[M+H] + :319.1252,found:319.1250.HPLC(AD-H,n-hexane/isopropanol=90/10,flow rate=1.0mL/min,l=220nm)tR=30.7min(major),38.2min(minor).
although the foregoing embodiments have been described in some, but not all embodiments of the invention, other embodiments may be obtained according to the present embodiments without departing from the scope of the invention.

Claims (10)

1. An alpha-carbon chiral phosphine compound, which is characterized by having a structure shown in a formula I:
Figure FDA0004073659280000011
in the formula I, the R 1 Is C 1~8 Alkyl, C of (2) 3~8 Cycloalkyl, C 1~8 Alkoxy, amino, aryl or substituted aryl groups, said R 1 The substituent on the substituted aryl is fluorine, chlorine, bromine, nitro, trifluoromethyl, C 1~4 Alkyl and C of (C) 1~4 At least one of the alkoxy groups of (a);
the R is 2 Is C 1~4 Alkyl, aryl, substituted aryl or thienyl, R 2 The substituent on the substituted aryl is fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1~4 Alkyl, C of (2) 1~4 Alkoxy, C 1~4 At least one of an alkoxy group, an ester group and a cyano group.
2. The alpha-carbon chiral phosphine compound according to claim 1, wherein said R 1 Is phenyl group,
Figure FDA0004073659280000012
Figure FDA0004073659280000013
MeO-, etO-, or
Figure FDA0004073659280000017
The R is 2 Is phenyl, naphthyl,
Figure FDA0004073659280000014
Figure FDA0004073659280000015
3. The α -carbon chiral phosphine compound according to claim 2, wherein the α -carbon chiral phosphine compound has any one of the following structures:
Figure FDA0004073659280000016
Figure FDA0004073659280000021
4. a process for producing an α -carbon chiral phosphine compound according to any one of claims 1 to 3, which comprises the steps of:
in a protective gas atmosphere, carrying out asymmetric boron protonation reaction on a dienylphosphine oxide compound with a structure shown in a formula II, pinacol boric acid ester, a copper (I) catalyst, a chiral ligand, an organic alkaline compound and a proton additive in a polar organic solvent to obtain the alpha-carbon chiral phosphine compound; the chiral ligand is a cyclic phosphine ligand (S, S) -Ph-BPE or a cyclic phosphine ligand (R, R) -Ph-BPE;
Figure FDA0004073659280000022
5. the method according to claim 4, wherein the copper (I) catalyst is CuCl, cuBr, cuI, cuOAc, cuTc and Cu (CH) 3 CN) 4 PF 6 One or more of the following.
6. The method according to claim 4, wherein the temperature of the asymmetric boron protonation reaction is-30 to-60 ℃.
7. The process according to claim 4, wherein the organic basic compound is sodium t-butoxide.
8. The method of claim 4, wherein the proton additive is methanol.
9. The preparation method according to claim 4, wherein the molar ratio of the dienylphosphine oxide compound of the structure represented by formula II to the pinacol borate is 1 (1-2);
the mol ratio of the alkenyl phosphine oxide compound with the structure shown in the formula II to the copper (I) catalyst is 1:0.05;
the mol ratio of the dienylphosphine oxide with the structure shown in the formula II to the chiral ligand is 1:0.06;
the mol ratio of the alkenyl phosphine oxide compound with the structure shown in the formula II to the proton additive is 1:2;
the molar ratio of the alkenyl phosphine oxide compound with the structure shown in the formula II to the organic alkaline compound is 1:0.2.
10. The method of claim 6, wherein the copper (I) catalyst is CuOAc; the temperature of the asymmetric boron protonation reaction is-55 ℃.
CN202310064532.0A 2023-01-13 2023-01-13 Alpha-carbon chiral phosphine compound and preparation method thereof Pending CN116082401A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310064532.0A CN116082401A (en) 2023-01-13 2023-01-13 Alpha-carbon chiral phosphine compound and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310064532.0A CN116082401A (en) 2023-01-13 2023-01-13 Alpha-carbon chiral phosphine compound and preparation method thereof

Publications (1)

Publication Number Publication Date
CN116082401A true CN116082401A (en) 2023-05-09

Family

ID=86186623

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310064532.0A Pending CN116082401A (en) 2023-01-13 2023-01-13 Alpha-carbon chiral phosphine compound and preparation method thereof

Country Status (1)

Country Link
CN (1) CN116082401A (en)

Similar Documents

Publication Publication Date Title
Wang et al. Nickel/copper-cocatalyzed decarbonylative silylation of acyl fluorides
Lu et al. Enantioselective alkynylation of aromatic aldehydes catalyzed by new chiral amino alcohol-based ligands
Kurihara et al. An N‐Linked Bidentate Phosphoramidite Ligand (N‐Me‐BIPAM) for Rhodium‐Catalyzed Asymmetric Addition of Arylboronic Acids to N‐Sulfonylarylaldimines
JP2004505091A (en) Phosphane ligands having an adamantyl group, their preparation and their use in catalytic reactions
EP2556077B1 (en) Monophosphorus ligands and their use in cross-coupling reactions
CN113185404B (en) 1, 2-biaxial chiral biaryl compound and preparation method and application thereof
CN113387876B (en) Nickel-catalyzed direct reduction cross-coupling method for heterocyclic phosphonium salt and aryl bromide and product
Lu et al. Dipeptide-derived multifunctional phosphonium salt as a catalyst to synthesize highly functionalized chiral cyclopentanes
JP4464388B2 (en) Phosphine compound, intermediate, palladium complex, and method for producing unsaturated compound using the complex
US20070088166A1 (en) Clickphosphines for transition metal-catalyzed reactions
CN110494439B (en) Chiral biphenyl diphosphine ligand and preparation method thereof
CN109836457B (en) High-steric-hindrance chiral P, N, N ligand and preparation method and application thereof
CN110386854A (en) A kind of preparation method of the aryl alkynes of visible light catalytic
JP4934823B2 (en) Silicon-containing cross-coupling reagent and method for producing organic compound using the same
CN116082401A (en) Alpha-carbon chiral phosphine compound and preparation method thereof
Šebesta et al. New [5] ferrocenophane diphosphine ligands for Pd-catalyzed allylic substitution
CN113402553B (en) Phosphine ligand of 2-alkyl-indole skeleton, preparation method and application thereof
Mešková et al. The development of an approach toward sterically-hindered chiral 2′-aryl-1, 1′-binaphthalenes functionalized at position 2
CN114907404A (en) 5- (2- (disubstituted phosphino) phenyl) -1-alkyl-1H-pyrazolylphosphine ligand and preparation method and application thereof
CN113292598A (en) Axial chiral biaryl compound with P-stereocenter and synthesis method and application thereof
JP2004238362A (en) OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT, ITS PRODUCTION METHOD AND METHOD FOR PRODUCING OPTICALLY ACTIVE alpha-AMINO ACID DERIVATIVE USING THE SALT AS PHASE-TRANSFER CATALYST
Jiang et al. Catalytic enantioselective synthesis of secondary alcohols using C2-symmetric diamino diol ligands
GB2544574B (en) Process
CN110627831A (en) Bibiaryl acetal phosphines, their preparation and use in coupling reactions
JP5568976B2 (en) Polysubstituted phosphine compound and catalyst containing the phosphine compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination